https://ncoda.org/resource/acalabrutinib-calquence-in-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma/ 2025-03-27T01:08:43+00:00 https://ncoda.org/resource/pqi-prevention-and-treatment-of-cancer-associated-venous-thromboembolic-disease/ 2025-03-27T01:12:33+00:00 https://ncoda.org/resource/pqi-pralsetinib-gavreto-management-for-metastatic-ret-fusion-positive-non-small-cell-lung-cancer/ 2025-03-27T01:12:46+00:00 https://ncoda.org/resource/pqi-ponatinib-iclusig-patient-management/ 2025-03-27T01:13:11+00:00 https://ncoda.org/resource/pqi-pharmacists-role-in-the-interpretation-and-application-of-next-generation-sequencing-ngs/ 2025-03-27T01:13:24+00:00 https://ncoda.org/resource/pqi-patient-screening-for-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma/ 2025-03-27T01:13:54+00:00 https://ncoda.org/resource/pqi-parp-inhibitor-eligibility-in-ovarian-cancer/ 2025-03-27T01:14:09+00:00 https://ncoda.org/resource/pqi-oral-formulation-of-decitabine-and-cedazuridine-inqovi-for-hematological-malignancies/ 2025-03-27T01:15:25+00:00 https://ncoda.org/resource/pqi-niraparib-zejula-dose-modifications-based-on-weight-and-platelet-counts/ 2025-03-27T01:15:38+00:00 https://ncoda.org/resource/adagrasib-krazati/ 2025-03-27T01:16:02+00:00 https://ncoda.org/resource/advanced-systemic-mastocytosis-patient-diagnostic-algorithm/ 2025-03-27T01:16:26+00:00 https://ncoda.org/resource/afatinib-gilotrif-management-in-non-small-cell-lung-cancer/ 2025-03-27T01:16:32+00:00 https://ncoda.org/resource/androgen-deprivation-therapy-with-relugolix-orgovyx/ 2025-03-27T01:16:39+00:00 https://ncoda.org/resource/axitinib-inlyta-plus-pembrolizumab-keytruda-for-advanced-renal-cell-carcinoma/ 2025-03-27T01:17:17+00:00 https://ncoda.org/resource/bortezomib-velcade-in-the-first-line-management-for-multiple-myeloma/ 2025-03-27T01:17:27+00:00 https://ncoda.org/resource/cabazitaxel-jevtana-for-patients-with-metastatic-castration-resistant-prostate-cancer/ 2025-03-27T01:17:40+00:00 https://ncoda.org/resource/cabozantinib-cabometyx/ 2025-03-27T01:17:47+00:00 https://ncoda.org/resource/cdk4-6-inhibitors-in-hr-her2-advanced-breast-cancer/ 2025-03-27T01:18:17+00:00 https://ncoda.org/resource/cemiplimab-rwlc-libtayo-patient-management/ 2025-03-27T01:18:23+00:00 https://ncoda.org/resource/chemotherapy-induced-peripheral-neuropathy/ 2025-03-27T01:18:37+00:00 https://ncoda.org/resource/chemotherapy-induced-nausea-and-vomiting/ 2025-03-27T01:18:44+00:00 https://ncoda.org/resource/pqi-chemotherapy-oncolytic-antiemetic-induced-constipation/ 2025-03-27T01:19:02+00:00 https://ncoda.org/resource/pqi-clonoseq-next-generation-sequencing-for-minimal-residual-disease-testing-in-multiple-myeloma/ 2025-03-27T01:19:09+00:00 https://ncoda.org/resource/pqi-clonoseq-next-generation-sequencing-for-minimum-residual-disease-testing-in-chronic-lymphocytic-leukemia/ 2025-03-27T01:19:16+00:00 https://ncoda.org/resource/pqi-durvalumab-imfinzi-therapy-overview/ 2025-03-27T01:20:26+00:00 https://ncoda.org/resource/pqi-duvelisib-copiktra-for-chronic-lymphocytic-leukemia/ 2025-03-27T01:21:09+00:00 https://ncoda.org/resource/pqi-elacestrant-orserdu/ 2025-03-27T01:21:16+00:00 https://ncoda.org/resource/pqi-enzalutamide-xtandi-in-castration-resistant-prostate-cancer-or-metastatic-castration-sensitive-prostate-cancer/ 2025-03-27T01:21:48+00:00 https://ncoda.org/resource/pqi-erythropoietin-stimulating-agent-ineligibility-in-myelodysplastic-syndromes/ 2025-03-27T01:21:56+00:00 https://ncoda.org/resource/pqi-estrogen-receptor-1-esr1-mutation-testing-in-metastatic-hormone-receptor-positive-human-epidermal-growth-factor-receptor-2-negative-breast-cancer/ 2025-03-27T01:22:03+00:00 https://ncoda.org/resource/pqi-exercise-during-cancer-treatment/ 2025-03-27T01:22:08+00:00 https://ncoda.org/resource/pqi-fertility-and-the-oncology-patient/ 2025-03-27T01:22:27+00:00 https://ncoda.org/resource/pqi-fgfr-inhibitor-side-effect-management/ 2025-03-27T01:22:34+00:00 https://ncoda.org/resource/pqi-fostamatinib-tavalisse-use-in-chronic-immune-thrombocytopenia/ 2025-03-27T01:22:40+00:00 https://ncoda.org/resource/pqi-futibatinib-lytgobi-adverse-effects-and-supportive-care-management/ 2025-03-27T01:22:55+00:00 https://ncoda.org/resource/pqi-general-survivorship-considerations/ 2025-03-27T01:23:12+00:00 https://ncoda.org/resource/pqi-glofitamab-gxbm-columvi-for-the-treatment-of-relapsed-or-refractory-large-b-cell-lymphoma/ 2025-03-27T01:23:29+00:00 https://ncoda.org/resource/pqi-granisetron-transdermal-system-sancuso-for-chemotherapy-induced-nausea-and-vomiting/ 2025-03-27T01:23:33+00:00 https://ncoda.org/resource/pqi-imetelstat-rytelo-in-the-treatment-of-low-to-intermediate-1-risk-myelodysplastic-syndromes-mds/ 2025-03-27T01:24:04+00:00 https://ncoda.org/resource/pqi-isatuximab-irfc-sarclisa-in-patients-with-relapsed-refractory-multiple-myeloma/ 2025-03-27T01:24:26+00:00 https://ncoda.org/resource/pqi-isatuximab-irfc-sarclisa-regimens-in-1q21-gain-amplification-relapsed-refractory-multiple-myeloma/ 2025-03-27T01:24:36+00:00 https://ncoda.org/resource/pqi-ixazomib-ninlaro-in-the-treatment-of-multiple-myeloma/ 2025-03-27T01:24:48+00:00 https://ncoda.org/resource/pqi-larotrectinib-vitrakvi-genomic-testing-management/ 2025-03-27T01:24:54+00:00 https://ncoda.org/resource/pqi-liposomal-daunorubicin-cytarabine-vyxeos-management/ 2025-03-27T01:24:59+00:00 https://ncoda.org/resource/pqi-loncastuximab-tesirine-lpyl-zynlonta-in-relapsed-refractory-large-b-cell-lymphoma/ 2025-03-27T01:25:10+00:00 https://ncoda.org/resource/pqi-lorlatinib-lorbrena-clinical-management/ 2025-03-27T01:25:15+00:00 https://ncoda.org/resource/pqi-lurbinectedin-zepzelca-for-small-cell-lung-cancer/ 2025-03-27T01:25:20+00:00 https://ncoda.org/resource/pqi-management-of-alpelisib-piqray-induced-hyperglycemia/ 2025-03-27T01:25:25+00:00 https://ncoda.org/resource/pqi-management-of-hyperphosphatemia-with-a-low-phosphorous-diet/ 2025-03-27T01:25:30+00:00 https://ncoda.org/resource/pqi-managing-egfr-inhibitor-induced-rash/ 2025-03-27T01:25:35+00:00 https://ncoda.org/resource/pqi-managing-immunotherapy-treatment-related-rash/ 2025-03-27T01:25:40+00:00 https://ncoda.org/resource/pqi-managing-tki-induced-hand-foot-skin-reaction/ 2025-03-27T01:25:45+00:00 https://ncoda.org/resource/pqi-margetuximab-cmkb-margenza-management/ 2025-03-27T01:25:50+00:00 https://ncoda.org/resource/pqi-medication-induced-hand-foot-syndrome/ 2025-03-27T01:25:55+00:00 https://ncoda.org/resource/pqi-mirvetuximab-soravtansine-gynx-elahere-for-patients-with-platinum-resistant-ovarian-fallopian-tube-or-primary-peritoneal-cancer/ 2025-03-27T01:26:00+00:00 https://ncoda.org/resource/pqi-netupitant-fosnetupitant-and-palonosetron-akynzeo-for-chemotherapy-induced-nausea-and-vomiting/ 2025-03-27T01:26:05+00:00 https://ncoda.org/resource/pqi-obinutuzumab-gazyva-for-chronic-lymphocytic-leukemia-and-follicular-lymphoma/ 2025-03-27T01:26:31+00:00 https://ncoda.org/resource/pqi-olanzapine-zyprexa-in-chemotherapy-induced-nausea-and-vomiting/ 2025-03-27T01:26:39+00:00 https://ncoda.org/resource/pqi-olaparib-lynparza-expansion-with-bevacizumab-avastin/ 2025-03-27T01:26:45+00:00 https://ncoda.org/resource/pqi-olaparib-lynparza-adverse-event-management/ 2025-03-27T01:26:52+00:00 https://ncoda.org/resource/pqi-olaparib-lynparza-clinical-management/ 2025-03-27T01:26:57+00:00 https://ncoda.org/resource/pqi-oncolytic-induced-diarrhea/ 2025-03-27T01:27:03+00:00 https://ncoda.org/resource/pqi-opioid-induced-constipation/ 2025-03-27T01:29:05+00:00 https://ncoda.org/resource/pqi-overview-of-breast-cancer-survivorship/ 2025-03-27T01:29:10+00:00 https://ncoda.org/resource/pqi-osimertinib-tagrisso-in-egfr-positive-non-small-cell-lung-cancer/ 2025-03-27T01:29:16+00:00 https://ncoda.org/resource/pqi-proactive-symptom-management-in-myelofibrosis/ 2025-03-27T13:49:53+00:00 https://ncoda.org/resource/pqi-radium-ra-223-dichloride-xofigo-management/ 2025-03-27T13:53:59+00:00 https://ncoda.org/resource/pqi-ropeginterferon-alfa-2b-njft-besremi-use-in-polycythemia-vera/ 2025-03-27T14:12:15+00:00 https://ncoda.org/resource/pqi-ripretinib-qinlock-for-treatment-of-adults-with-advanced-gastrointestinal-stromal-tumors/ 2025-03-27T14:28:13+00:00 https://ncoda.org/resource/pqi-ruxolitinib-jakafi-managing-myelofibrosis-patients/ 2025-03-27T14:28:33+00:00 https://ncoda.org/resource/pqi-selinexor-xpovio-patient-management/ 2025-03-27T14:32:08+00:00 https://ncoda.org/resource/pqi-selpercatinib-retevmo-genomic-testing-management/ 2025-03-27T14:37:45+00:00 https://ncoda.org/resource/pqi-selpercatinib-retevmo-management/ 2025-03-27T14:55:47+00:00 https://ncoda.org/resource/pqi-siltuximab-sylvant-in-patients-with-idiopathic-multicentric-castleman-disease/ 2025-03-27T14:57:38+00:00 https://ncoda.org/resource/pqi-social-determinants-of-health-in-cancer/ 2025-03-27T15:03:10+00:00 https://ncoda.org/resource/pqi-smoking-cessation/ 2025-03-27T15:04:30+00:00 https://ncoda.org/resource/pqi-sonidegib-odomzo-patient-management/ 2025-03-27T15:10:12+00:00 https://ncoda.org/resource/pqi-sotorasib-lumakras-companion-diagnostics-qiagen-therascreen-kras-rgq-pcr-kit-and-guardant360-cdx/ 2025-03-27T15:14:52+00:00 https://ncoda.org/resource/pqi-sotorasib-lumakras-for-kras-g12c-mutated-non-small-cell-lung-cancer-nsclc/ 2025-03-27T15:17:15+00:00 https://ncoda.org/resource/pqi-stomatitis-prophylaxis-during-everolimus-afinitor-therapy/ 2025-03-27T15:18:43+00:00 https://ncoda.org/resource/pqi-tafasitamab-cxix-monjuvi-for-relapsed-refractory-diffuse-large-b-cell-lymphoma/ 2025-03-27T15:20:31+00:00 https://ncoda.org/resource/pqi-talazoparib-talzenna-and-enzalutamide-xtandi-in-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/ 2025-03-27T15:23:03+00:00 https://ncoda.org/resource/pqi-tazemetostat-tazverik-management-in-relapsed-refractory-follicular-lymphoma/ 2025-03-27T15:25:30+00:00 https://ncoda.org/resource/pqi-tebentafusp-tebn-kimmtrak-for-patients-with-unresectable-or-metastatic-uveal-melanoma/ 2025-03-27T15:28:09+00:00 https://ncoda.org/resource/pqi-telotristat-ethyl-xermelo-for-the-management-of-carcinoid-syndrome-diarrhea/ 2025-03-27T15:30:12+00:00 https://ncoda.org/resource/pqi-tepotinib-tepmetko-for-non-small-cell-lung-cancer-with-met-exon-14-alterations/ 2025-03-27T15:36:21+00:00 https://ncoda.org/resource/pqi-the-role-of-pharmacy-in-equitable-breast-cancer-care/ 2025-03-27T16:17:31+00:00 https://ncoda.org/resource/pqi-tisotumab-vedotin-tftv-tivdak-management/ 2025-03-27T16:19:56+00:00 https://ncoda.org/resource/pqi-toripalimab-loqtorzi-for-recurrent-or-metastatic-nasopharyngeal-carcinoma/ 2025-03-27T16:24:32+00:00 https://ncoda.org/resource/pqi-tremelimumab-actl-imjudo-patient-management/ 2025-03-27T16:28:10+00:00 https://ncoda.org/resource/pqi-use-of-belumosudil-rezurock-for-the-treatment-of-chronic-graft-versus-host-disease/ 2025-03-28T14:20:35+00:00 https://ncoda.org/resource/pqi-use-of-rasburicase-elitek-for-treatment-of-tumor-lysis-syndrome/ 2025-03-28T14:23:04+00:00 https://ncoda.org/resource/pqi-vaccination-for-non-transplant-patients-with-cancer/ 2025-03-28T14:28:03+00:00 https://ncoda.org/resource/pqi-vegf-inhibitor-induced-hypertension/ 2025-03-28T14:34:17+00:00 https://ncoda.org/resource/pqi-management-of-abemaciclib-verzenio-associated-diarrhea/ 2025-03-31T20:00:52+00:00 https://ncoda.org/resource/abiraterone-acetate-yonsa-patient-selection-and-management/ 2025-03-31T20:04:15+00:00 https://ncoda.org/resource/capecitabine-xeloda-a-new-approach-to-dosing-and-side-effect-management/ 2025-03-31T20:07:00+00:00 https://ncoda.org/resource/pqi-neratinib-nerlynx-diarrhea-management/ 2025-03-31T20:14:22+00:00 https://ncoda.org/resource/pqi-pacritinib-vonjo-in-cytopenic-myelofibrosis/ 2025-03-31T20:16:40+00:00 https://ncoda.org/resource/pqi-temozolomide-temodar-for-glioblastoma-multiforme/ 2025-03-31T20:23:17+00:00 https://ncoda.org/resource/pqi-ibrutinib-imbruvica-management-in-pediatric-patients/ 2025-04-07T19:54:54+00:00 https://ncoda.org/resource/pqi-ibrutinib-imbruvica-expansion-with-obinutuzumab-gazyva/ 2025-04-07T19:57:14+00:00 https://ncoda.org/resource/pqi-ibrutinib-imbruvica-management/ 2025-04-07T19:57:14+00:00 https://ncoda.org/resource/healthy-cancer-comeback/ 2025-04-10T15:53:30+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/childhood-cancer-awareness-month/ 2025-04-10T15:55:13+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Hero_Website-graphic-2.png https://ncoda.org/resource/health-advocacy/ 2025-04-10T15:56:40+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/ncoda-residency-and-capecitabine-resource/ 2025-04-10T16:10:09+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/ohio-state-drug-repository-program/ 2025-04-10T16:35:55+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/pharmacy-careers-and-ncoda-pso/ 2025-04-10T16:37:30+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/international-womens-day-2/ 2025-04-10T17:12:16+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/collaboration-in-oncology-pharmacy-care/ 2025-04-10T17:21:22+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/the-chemo-tapes/ 2025-04-10T17:29:58+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-1.png https://ncoda.org/resource/oncology-conversations/ 2025-04-10T17:31:49+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-1.png https://ncoda.org/resource/role-of-oncology-social-worker/ 2025-04-10T20:16:24+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/community-pharmacy/ 2025-04-10T20:16:52+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/mentoring-students-and-tl-dr-pjarmacy/ 2025-04-10T20:17:21+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/colorectal-cancer-awareness-month/ 2025-04-10T20:17:49+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/mental-illness-and-burnout/ 2025-04-10T20:19:32+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/cancer-wellness-and-exercise/ 2025-04-10T20:20:20+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/cancer-care-in-nigeri/ 2025-04-10T20:20:51+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/heated-intraperitoneal-chemotherapy/ 2025-04-10T20:21:20+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/drug-shortages/ 2025-04-10T20:21:50+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/brain-cancer-awareness-month/ 2025-04-10T20:24:00+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/oncology-pharmacy-technicians/ 2025-04-10T20:24:27+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/sugar-bloom/ 2025-04-10T20:24:55+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/anticoagulant-therapy/ 2025-04-10T20:25:20+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/cancer-immunotherapy/ 2025-04-10T20:26:47+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/about-herbs/ 2025-04-10T20:27:29+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/oral-cancer-care/ 2025-04-10T20:27:56+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/the-two-percent-way/ 2025-04-10T20:28:21+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Hero_Website-graphic-2.png https://ncoda.org/resource/fertility-preservation/ 2025-04-10T20:28:47+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/childhood-illness/ 2025-04-10T20:29:10+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/patient-navigation-and-triage-cancer/ 2025-04-10T20:29:34+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/pharmacy-path-and-venetoclax/ 2025-04-10T20:30:00+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/city-of-hope-chicago/ 2025-04-10T20:30:25+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/intravenous-iron-products-for-anemia-in-cancer/ 2025-04-10T20:30:45+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/li-fraumeni-syndrome/ 2025-04-10T20:31:44+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/thinking-our-way-to-chronic-health/ 2025-04-10T20:32:10+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/workplace-well-being/ 2025-04-10T20:32:37+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/molecular-testing-and-targeted-treatment-in-colorectal-cancer/ 2025-04-10T20:33:04+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/sit-stay-heal/ 2025-04-10T20:33:27+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/cervical-cancer-updates-and-disparities/ 2025-04-10T20:33:48+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/urology-clinic-best-practices/ 2025-04-10T20:34:53+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/ctdna-testing-in-gi-cancer/ 2025-04-10T20:35:33+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/oncology-pharmacy-technician-in-england/ 2025-04-10T20:36:01+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/iv-iron-therapy/ 2025-04-10T20:36:42+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/2024-ncoda-spring-forum/ 2025-04-10T20:37:58+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/pqi-ibrutinib-dosing-optimization/ 2025-04-11T17:53:01+00:00 https://ncoda.org/resource/pqi-vorasidenib-voranigo/ 2025-04-11T17:59:08+00:00 https://ncoda.org/resource/pqi-venetoclax-venclexta-use-in-chronic-lymphocytic-leukemia/ 2025-04-11T18:00:48+00:00 https://ncoda.org/resource/pqi-use-of-rucaparib-rubraca-and-indications/ 2025-04-11T18:04:40+00:00 https://ncoda.org/resource/pqi-tucatinib-tukysa-management/ 2025-04-11T18:07:22+00:00 https://ncoda.org/resource/pqi-tucatinib-tukysa-and-trastuzumab-in-her2-positive-metastatic-colorectal-cancer/ 2025-04-11T18:31:02+00:00 https://ncoda.org/resource/pqi-trilaciclib-cosela-management/ 2025-04-11T18:32:07+00:00 https://ncoda.org/resource/pqi-trifluridine-tipiracil-lonsurf-for-treatment-of-gastric-cancer/ 2025-04-11T18:33:15+00:00 https://ncoda.org/resource/pqi-trifluridine-and-tipiracil-lonsurf-for-metastatic-colorectal-cancer/ 2025-04-11T18:34:02+00:00 https://ncoda.org/resource/pqi-sorafenib-nexavar-for-the-treatment-of-hepatocellular-carcinoma-and-transition-to-second-line-regorafenib-stivarga/ 2025-04-11T19:06:04+00:00 https://ncoda.org/resource/pqi-ruxolitinib-jakafi-managing-treatment-of-polycythemia-vera/ 2025-04-11T19:20:45+00:00 https://ncoda.org/resource/pqi-regorafenib-stivarga-in-the-treatment-of-hepatocellular-carcinoma/ 2025-04-11T19:28:21+00:00 https://ncoda.org/resource/pqi-regorafenib-stivarga-in-metastatic-colorectal-cancer/ 2025-04-11T19:29:38+00:00 https://ncoda.org/resource/pqi-dpyd-testing-prior-to-fluoropyrimidine-treatment/ 2025-04-14T13:03:44+00:00 https://ncoda.org/resource/pqi-non-hormonal-birth-control-alternative-with-lactic-acid-citric-acid-potassium-bitartrate-phexxi/ 2025-04-14T13:49:32+00:00 https://ncoda.org/resource/pediatric-oncology/ 2025-04-14T19:24:43+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/car-t-therapy/ 2025-04-14T19:36:01+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/personal-story-and-cone-health/ 2025-04-14T19:44:10+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/drugs-and-the-fda/ 2025-04-14T19:57:14+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/bonus-legislative-episode/ 2025-04-14T20:39:32+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/legislation-impacting-the-world-of-oncology/ 2025-04-14T21:01:33+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/myeloproliferative-neoplasms/ 2025-04-14T21:31:39+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/pqi-in-action-darolutamide-in-the-treatment-of-non-metastatic-castration-resistant-prostate-cancer-nmcrpc/ 2025-04-14T22:43:33+00:00 https://ncoda.org/resource/pqi-in-action-darolutamide-in-the-treatment-of-non-metastatic-castration-resistant-prostate-cancer-darolutamide-in-combination-with-docetaxel-for-metastatic-hormone-sensitive-prostate-cancer/ 2025-04-14T22:45:16+00:00 https://ncoda.org/resource/pqi-in-action-darolutamide-in-the-treatment-of-non-metastatic-castration-resistant-prostate-cancer-nmcrpc-2/ 2025-04-14T22:46:22+00:00 https://ncoda.org/resource/pqi-in-action-erythropoietin-stimulating-agent-ineligibility-in-myelodysplastic-syndromes/ 2025-04-14T22:50:53+00:00 https://ncoda.org/resource/pqi-in-action-extolling-the-benefits-of-identifying-polycythemia-vera-patients-and-myelofibrosis-within-medically-integrated-dispensing-practices/ 2025-04-14T22:51:55+00:00 https://ncoda.org/resource/pqi-in-action-larotrectinib-genomic-testing-management-and-overview/ 2025-04-14T22:55:33+00:00 https://ncoda.org/resource/pqi-in-action-liposomal-daunorubicin-cytarabine-vyxeos-management/ 2025-04-14T22:56:32+00:00 https://ncoda.org/resource/pqi-in-action-medically-integrated-dispensing-of-regorafenib-for-metastatic-colorectal-cancer-patients/ 2025-04-14T22:59:48+00:00 https://ncoda.org/resource/pqi-in-action-multidisciplinary-management-of-advanced-ovarian-cancer-patients-within-medically-integrated-pharmacy-practices/ 2025-04-14T23:01:25+00:00 https://ncoda.org/resource/pqi-in-action-multidisciplinary-management-of-metastatic-colorectal-cancer-patients-within-medically-integrated-pharmacy-practices/ 2025-04-14T23:02:54+00:00 https://ncoda.org/resource/pqi-in-action-optimizing-venetoclax-treatment-of-acute-myeloid-leukemia/ 2025-04-14T23:05:22+00:00 https://ncoda.org/resource/pqi-in-action-oral-formulation-of-decitabine-and-cedazuridine-inqovi-for-hematological-malignancies/ 2025-04-14T23:07:12+00:00 https://ncoda.org/resource/pqi-in-action-pacritinib-vonjo-in-cytopenic-myelofibrosis/ 2025-04-14T23:09:14+00:00 https://ncoda.org/resource/pqi-in-action-proactive-symptom-management-in-myelofibrosis/ 2025-04-14T23:10:23+00:00 https://ncoda.org/resource/pqi-in-action-putting-gilteritinib-xospata-for-relapsed-refractory-acute-myeloid-leukemia-aml-into-action/ 2025-04-14T23:13:08+00:00 https://ncoda.org/resource/pqi-in-action-radium-ra-223-dichloride-xofigo-in-castrate-resistant-prostate-cancer-crpc/ 2025-04-14T23:14:09+00:00 https://ncoda.org/resource/pqi-in-action-ripretinib-qinlock-for-treatment-of-adults-with-advanced-gastrointestinal-stromal-tumors/ 2025-04-14T23:15:03+00:00 https://ncoda.org/resource/pqi-in-action-ropeginterferon-alfa-2b-njft-besremi-use-in-polycythemia-vera/ 2025-04-14T23:16:05+00:00 https://ncoda.org/resource/pqi-in-action-sacituzumab-govitecan-trodelvy-management-of-neutropenia-and-diarrhea/ 2025-04-14T23:18:12+00:00 https://ncoda.org/resource/venetoclax-in-aml-pqi-ad-updates/ 2025-04-14T23:30:17+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/pqi-in-action-siltuximab-sylvant-in-patients-with-idiopathic-multicentric-castleman-disease/ 2025-04-14T23:31:38+00:00 https://ncoda.org/resource/pqi-in-action-telotristat-ethyl-carcinoid-syndrome-diarrhea/ 2025-04-14T23:34:25+00:00 https://ncoda.org/resource/pqi-in-action-tepotinib-tepmetko-for-non-small-cell-lung-cancerwith-met-exon-14-alterations/ 2025-04-14T23:35:32+00:00 https://ncoda.org/resource/pqi-in-action-tisotumab-vedotin-tftv-tivdak-management/ 2025-04-14T23:36:46+00:00 https://ncoda.org/resource/pqi-in-action-tivozanib-fotivda-for-relapse-or-refractory-advanced-renal-cell-carcinoma/ 2025-04-14T23:37:45+00:00 https://ncoda.org/resource/pqi-in-action-trifluridine-and-tipiracil-lonsurf-bevacizumab-for-the-treatment-of-metastatic-colorectal-cancer/ 2025-04-14T23:39:32+00:00 https://ncoda.org/resource/pqi-in-action-trilaciclib-cosela-management/ 2025-04-14T23:40:34+00:00 https://ncoda.org/resource/the-importance-of-the-multidisciplinary-team/ 2025-04-14T23:43:16+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/pqi-in-action-tucatinib-tukysa-management/ 2025-04-14T23:44:10+00:00 https://ncoda.org/resource/pqi-in-action-tucatinib-tukysa-management-2/ 2025-04-14T23:46:00+00:00 https://ncoda.org/resource/pqi-in-action-tucatinib-tukysa-management-3/ 2025-04-14T23:48:29+00:00 https://ncoda.org/resource/pqi-in-action-use-of-rasburicase-elitek-for-treatment-of-tumor-lysis-syndrome/ 2025-04-14T23:50:20+00:00 https://ncoda.org/resource/health-disparities-in-cancer-screenings/ 2025-04-15T00:01:29+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/moffitt-clinical-pharmacy-program/ 2025-04-15T00:13:37+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/pqi-in-action-venetoclax-venclexta-for-the-treatment-of-acute-myeloid-leukemia/ 2025-04-15T00:19:54+00:00 https://ncoda.org/resource/pqi-in-action-venetoclax-venclexta-use-in-chronic-lymphocytic-leukemia/ 2025-04-15T00:21:17+00:00 https://ncoda.org/resource/pqi-in-action-zanubrutinib-brukinsa-patient-selection-and-management-in-mantle-cell-lymphoma/ 2025-04-15T00:22:51+00:00 https://ncoda.org/resource/pqi-in-action-zanubrutinib-brukinsa-patient-selection-and-management-in-mantle-cell-lymphoma-3/ 2025-04-15T00:25:32+00:00 https://ncoda.org/resource/brukinsa-zanubrutinib-for-treatment-of-relapsed-or-refractory-marginal-zone-lymphoma/ 2025-04-16T18:30:06+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-38.jpg https://ncoda.org/resource/brukinsa-zanubrutinib-for-treatment-of-mantle-cell-lymphoma/ 2025-04-16T18:31:58+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-38.jpg https://ncoda.org/resource/neratinib-for-extended-adjuvent-treatment-mip/ 2025-04-16T18:33:17+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-38.jpg https://ncoda.org/resource/ibrutinib-related-cardiac-toxicity/ 2025-04-16T18:38:05+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-36.jpg https://ncoda.org/resource/how-to-administer-akynzeo/ 2025-04-16T18:39:20+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-34.jpg https://ncoda.org/resource/neratinib-for-extended-adjuvent-treatment/ 2025-04-16T18:41:18+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-37.jpg https://ncoda.org/resource/brukinsa-zanubrutinib-for-treatment-of-waldenstroms-macroglobulinemia/ 2025-04-16T18:42:25+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-38.jpg https://ncoda.org/resource/brukinsa-zanubrutinib-for-treatment-of-chronic-lymphocytic-leukemia-cll-or-small-lymphocytic-lymphoma-sll/ 2025-04-16T18:43:14+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/NewsFeatureImage-38.jpg https://ncoda.org/resource/tukysa-tucatinib-educational-videos/ 2025-04-16T18:44:58+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/webinars-stock-image.jpg https://ncoda.org/resource/pqi-nirogacestat-ogsiveo-use-in-management-of-adults-with-progressing-desmoid-tumors-or-fibromatosis-or-aggressive-fibromatosis/ 2025-04-16T19:47:03+00:00 https://ncoda.org/resource/pqi-inavolisib-itovebi-patient-management/ 2025-04-16T19:49:06+00:00 https://ncoda.org/resource/regorafenib-treatment-support-kits/ 2025-04-16T21:00:10+00:00 https://ncoda.org/resource/pqi-in-action-tremelimumab-actl-imjudo-patient-management/ 2025-04-18T20:24:41+00:00 https://ncoda.org/resource/pqi-non-small-cell-lung-cancer-stage-iii-overview-and-patient-eligibility-of-durvalumab-imfinzi/ 2025-04-18T20:32:49+00:00 https://ncoda.org/resource/pqi-fam-trastuzumab-deruxtecan-nxki-enhertu-management/ 2025-04-18T20:33:16+00:00 https://ncoda.org/resource/patient-surveys/ 2025-04-29T14:27:17+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/CE_FeatureImage_MedicalAcronym_364x273.jpg https://ncoda.org/resource/pqi-advances-in-mrd-monitoring-for-diffuse-large-b-cell-lymphoma-dlbcl/ 2025-05-15T19:13:19+00:00 https://ncoda.org/resource/lorlatinib-in-practice/ 2025-05-15T22:53:26+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/Podcast-Episode-Feature-Image-9.jpg https://ncoda.org/resource/no-mas-melanomas/ 2025-05-15T22:57:55+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/05/Podcast-Episode-Feature-Image-12.jpg https://ncoda.org/resource/operationalizing-bispecifics-in-the-community-setting/ 2025-05-15T23:01:40+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/Podcast-Episode-Feature-Image-13.jpg https://ncoda.org/resource/exploring-clinical-trials-fda-approvals/ 2025-05-15T23:03:56+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/Podcast-Episode-Feature-Image-14.jpg https://ncoda.org/resource/interprofessional-oral-oncolytic-workflows/ 2025-05-15T23:08:04+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/Podcast-Episode-Feature-Image-15.jpg https://ncoda.org/resource/manta-cares/ 2025-05-15T23:17:47+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-17.jpg https://ncoda.org/resource/cancer-care-beyond-walls/ 2025-05-15T23:23:02+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-18.jpg https://ncoda.org/resource/international-womens-day/ 2025-05-15T23:26:00+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-19.jpg https://ncoda.org/resource/care-flash/ 2025-05-15T23:29:27+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-20.jpg https://ncoda.org/resource/leveraging-mobile-health/ 2025-05-15T23:31:47+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-21.jpg https://ncoda.org/resource/addressing-drug-shortages/ 2025-05-15T23:33:36+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-22.jpg https://ncoda.org/resource/sharita-howe/ 2025-05-15T23:43:05+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-23.jpg https://ncoda.org/resource/celebrating-the-season/ 2025-05-15T23:47:22+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-24.jpg https://ncoda.org/resource/stem-cell-transplant/ 2025-05-15T23:56:12+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-27.jpg https://ncoda.org/resource/olympian-breast-cancer-awareness/ 2025-05-15T23:58:08+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-28.jpg https://ncoda.org/resource/precision-medicine-in-oncology/ 2025-05-15T23:59:58+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-29.jpg https://ncoda.org/resource/sarcoma-landscape-emerging-treatments/ 2025-05-16T00:02:08+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-30.jpg https://ncoda.org/resource/navigating-cancer-and-mental-health/ 2025-05-16T00:04:07+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-31.jpg https://ncoda.org/resource/takeover-with-pat-connelly/ 2025-05-16T00:05:48+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-32.jpg https://ncoda.org/resource/sickle-cell-disease-insights/ 2025-05-16T00:07:52+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-33.jpg https://ncoda.org/resource/warriors-that-pray/ 2025-05-16T00:09:31+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-34.jpg https://ncoda.org/resource/mastering-patient-communication/ 2025-05-16T00:11:15+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-35.jpg https://ncoda.org/resource/car-t-cell-therapy-for-mm/ 2025-05-16T00:12:56+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-36.jpg https://ncoda.org/resource/breast-cancer-and-health-equity/ 2025-05-16T00:14:51+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-37.png https://ncoda.org/resource/nourishing-health/ 2025-05-16T00:16:03+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-38.jpg https://ncoda.org/resource/navigating-kidney-cancer/ 2025-05-16T00:18:05+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-39.jpg https://ncoda.org/resource/beyond-the-fire-wall/ 2025-05-16T00:20:02+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-40.jpg https://ncoda.org/resource/pqi-sacituzumab-govitecan-hziy-trodelvy-prophylaxis-and-management-of-adverse-events/ 2025-05-19T18:42:07+00:00 https://ncoda.org/resource/pqi-zolbetuximab-vyloy-for-gastroesophageal-cancers/ 2025-05-19T20:19:17+00:00 https://ncoda.org/resource/advancing-geriatric-oncology/ 2025-05-22T13:11:14+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/05/Podcast-Episode-Feature-Image-41.jpg https://ncoda.org/resource/honoring-her-legacy/ 2025-05-22T19:17:57+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/04/Podcast-Episode-Feature-Image-10.jpg https://ncoda.org/resource/supporting-survivors-at-work/ 2025-05-29T12:29:08+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/05/Podcast-Episode-Feature-Image-42.jpg https://ncoda.org/resource/pqi-in-action-zanubrutinib-brukinsa-patient-selection-and-management-in-mantle-cell-lymphoma-2/ 2025-05-29T13:36:07+00:00 https://ncoda.org/resource/ncoda-greece/ 2025-06-02T13:46:35+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/resource/cancer-pain/ 2025-06-02T19:26:59+00:00 https://ncoda.org/resource/supporting-patients-through-financial-assistance/ 2025-06-11T19:53:07+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/05/Podcast-Episode-Feature-Image-11.jpg https://ncoda.org/resource/inside-asco-2025/ 2025-06-18T13:07:20+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/06/Podcast-Episode-Feature-Image-43.jpg https://ncoda.org/resource/honoring-veterans/ 2025-07-01T14:43:20+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-26.jpg https://ncoda.org/resource/improving-veteran-care/ 2025-07-01T14:46:07+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-25.png https://ncoda.org/resource/staff-education-for-using-bispecific-t-cell-engagers/ 2025-07-01T20:09:32+00:00 https://ncoda.org/resource/inpatient-use-of-bispecific-t-cell-engagers/ 2025-07-01T20:17:41+00:00 https://ncoda.org/resource/bispecific-t-cell-engager-associated-cytokine-release-syndrome-crs-management-mid-sized/ 2025-07-01T20:21:00+00:00 https://ncoda.org/resource/bispecific-t-cell-engager-associated-cytokine-release-syndrome-crs-management-large/ 2025-07-01T20:36:19+00:00 https://ncoda.org/resource/bispecific-t-cell-engager-neurotoxicity-management-large/ 2025-07-01T20:39:18+00:00 https://ncoda.org/resource/bispecific-t-cell-engager-neurotoxicity-management-academic/ 2025-07-01T20:42:05+00:00 https://ncoda.org/resource/bispecific-t-cell-engager-neurotoxicity-management-mid-sized/ 2025-07-01T20:48:44+00:00 https://ncoda.org/resource/on-call-symptom-interventions-for-patients-receiving-bispecific-t-cell-engagers-mid-sized/ 2025-07-01T20:56:56+00:00 https://ncoda.org/resource/telephone-triage-of-patients-undergoing-bispecific-t-cell-engager-therapy-mid-sized/ 2025-07-01T20:58:42+00:00 https://ncoda.org/resource/on-call-responsibilities-for-nurses-managing-bispecific-t-cell-engagers-mid-sized/ 2025-07-01T21:01:53+00:00 https://ncoda.org/resource/bispecific-t-cell-engager-ordering-and-rems-compliance-mid-sized/ 2025-07-01T21:06:17+00:00 https://ncoda.org/resource/bispecific-t-cell-engager-billing-procedure-mid-sized/ 2025-07-01T21:09:44+00:00 https://ncoda.org/resource/transitioning-patients-on-bispecific-t-cell-engagers-between-care-settings-mid-sized/ 2025-07-01T23:50:20+00:00 https://ncoda.org/resource/abiraterone-acetate-treatment-support-kits/ 2025-07-02T21:14:08+00:00 https://ncoda.org/resource/treatment-support-kit-capecitabine/ 2025-07-02T21:15:24+00:00 https://ncoda.org/resource/neratinib-treatment-support-kits/ 2025-07-02T21:17:39+00:00 https://ncoda.org/resource/tivozanib-treatment-support-kits/ 2025-07-02T21:19:34+00:00 https://ncoda.org/resource/temozolomide-treatment-support-kits/ 2025-07-02T21:20:07+00:00 https://ncoda.org/resource/pqi-encorafenib-braftovi-cetuximab-erbitux-mfolfox6-for-braf-v600e-positive-metastatic-colorectal-cancer/ 2025-07-02T21:59:47+00:00 https://ncoda.org/resource/pqi-in-action-myelofibrosis/ 2025-07-17T17:54:45+00:00 https://ncoda.org/resource/pqi-bone-health-and-the-cancer-patient/ 2025-07-22T21:46:38+00:00 https://ncoda.org/resource/pqi-larotrectinib-vitrakvi-overview/ 2025-07-23T20:58:26+00:00 https://ncoda.org/resource/pqi-encorafenib-braftovi-and-binimetinib-mektovi-for-the-management-of-nsclc/ 2025-08-04T23:22:02+00:00 https://ncoda.org/resource/pqi-prophylaxis-and-management-of-skin-toxicities-with-amivantamab-rybrevant-and-lazertinib-lazcluze-treatment-the-cocoon-protocol/ 2025-08-08T12:46:14+00:00 https://ncoda.org/resource/abemaciclib-treatment-support-kits/ 2025-08-11T18:57:55+00:00 https://ncoda.org/resource/cabozantinib-treatment-support-kits/ 2025-08-11T19:01:22+00:00 https://ncoda.org/resource/fruquintinib-treatment-support-kits/ 2025-08-11T19:03:54+00:00 https://ncoda.org/resource/mirdametinib-treatment-support-kits/ 2025-08-11T19:06:34+00:00 https://ncoda.org/resource/nirogacestat-treatment-support-kits/ 2025-08-11T19:08:37+00:00 https://ncoda.org/resource/pqi-darolutamide-nubeqa-in-combination-with-docetaxel-taxotere-for-metastatic-hormone-sensitive-prostate-cancer/ 2025-08-20T00:01:08+00:00 https://ncoda.org/resource/pqi-zanidatamab-hrii-ziihera-for-the-management-of-biliary-tract-cancer/ 2025-08-20T23:14:15+00:00 https://ncoda.org/resource/head-and-neck-cancer-care/ 2025-08-28T13:57:45+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/08/Podcast-Episode-Feature-Image-44.jpg https://ncoda.org/resource/pqi-talectrectinib-ibtrozi-for-the-management-of-ros1-advanced-nsclc/ 2025-08-29T21:11:37+00:00 https://ncoda.org/resource/love-languages-in-cancer-care/ 2025-09-03T19:32:28+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/09/Podcast-Episode-Feature-Image-45.jpg https://ncoda.org/resource/pembrolizumab-management-for-advanced-or-metastatic-urothelial-carcinoma/ 2025-09-10T11:29:11+00:00 https://ncoda.org/resource/pqi-tivozanib-fotivda-for-relapsed-or-refractory-advanced-renal-cell-carcinoma/ 2025-09-11T10:42:57+00:00 https://ncoda.org/resource/firefighter-health-and-cancer-prevention/ 2025-09-11T13:38:04+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/09/Podcast-Episode-Feature-Image-46.jpg https://ncoda.org/resource/pqi-eflapegrastim-xnst-rolvedon-for-chemotherapy-induced-neutropenia/ 2025-09-17T12:18:47+00:00 https://ncoda.org/pes/daratumumab/ 2025-09-23T00:52:57+00:00 https://ncoda.org/pes/daratumumab-and-hyaluronidase/ 2025-09-23T00:57:04+00:00 https://ncoda.org/pes/lenalidomide-and-tafasitamab/ 2025-09-23T12:40:49+00:00 https://ncoda.org/pes/ropeginterferon-alfa-2b/ 2025-09-24T20:04:52+00:00 https://ncoda.org/pes/talquetamab/ 2025-09-24T22:14:04+00:00 https://ncoda.org/pes/tarlatamab/ 2025-09-24T22:27:41+00:00 https://ncoda.org/pes/tebentafusp/ 2025-09-24T22:38:57+00:00 https://ncoda.org/pes/teclistamab/ 2025-09-24T22:44:13+00:00 https://ncoda.org/pes/tislelizumab/ 2025-09-24T23:17:21+00:00 https://ncoda.org/pes/afatinib/ 2025-09-25T19:29:10+00:00 https://ncoda.org/pes/albumin-bound-paclitaxel/ 2025-09-25T19:29:55+00:00 https://ncoda.org/pes/alectinib/ 2025-09-25T19:31:11+00:00 https://ncoda.org/pes/alpelisib/ 2025-09-25T19:32:55+00:00 https://ncoda.org/pes/apalutamide/ 2025-09-25T19:56:06+00:00 https://ncoda.org/pes/avatrombopag/ 2025-09-25T20:18:54+00:00 https://ncoda.org/pes/axitinib/ 2025-09-25T20:20:02+00:00 https://ncoda.org/pes/azacitidine-oral/ 2025-09-25T20:22:01+00:00 https://ncoda.org/pes/azacitidine/ 2025-09-25T20:24:04+00:00 https://ncoda.org/pes/belinostat/ 2025-09-25T20:29:02+00:00 https://ncoda.org/pes/belumosudil/ 2025-09-25T20:30:18+00:00 https://ncoda.org/pes/belzutifan/ 2025-09-25T20:31:42+00:00 https://ncoda.org/pes/bendamustine-and-rituximab/ 2025-09-25T20:34:12+00:00 https://ncoda.org/pes/bevacizumab-and-paclitaxel/ 2025-09-25T20:37:51+00:00 https://ncoda.org/pes/bexarotene/ 2025-09-25T21:41:59+00:00 https://ncoda.org/pes/bicalutamide/ 2025-09-25T21:43:19+00:00 https://ncoda.org/pes/bleomycin-etoposide-and-cisplatin/ 2025-09-25T21:44:55+00:00 https://ncoda.org/pes/cabazitaxel/ 2025-09-25T21:58:00+00:00 https://ncoda.org/pes/capmatinib/ 2025-09-25T22:03:03+00:00 https://ncoda.org/pes/carboplatin/ 2025-09-25T22:04:17+00:00 https://ncoda.org/pes/carboplatin-and-gemcitabine/ 2025-09-25T22:10:38+00:00 https://ncoda.org/pes/carboplatin-and-paclitaxel/ 2025-09-25T22:11:53+00:00 https://ncoda.org/pes/carboplatin-and-pemetrexed/ 2025-09-25T22:13:49+00:00 https://ncoda.org/pes/ceritinib/ 2025-09-25T22:48:08+00:00 https://ncoda.org/pes/cetuximab-and-irinotecan/ 2025-09-25T22:50:48+00:00 https://ncoda.org/pes/cisplatin-and-gemcitabine/ 2025-09-25T22:54:40+00:00 https://ncoda.org/pes/cisplatin-and-pemetrexed/ 2025-09-25T23:12:46+00:00 https://ncoda.org/pes/cyclophosphamide/ 2025-09-25T23:25:56+00:00 https://ncoda.org/pes/cytarabine-and-daunorubicin-73/ 2025-09-25T23:52:43+00:00 https://ncoda.org/pes/dacomitinib/ 2025-09-26T00:19:27+00:00 https://ncoda.org/pes/darolutamide/ 2025-09-26T00:20:39+00:00 https://ncoda.org/pes/dasatinib/ 2025-09-26T00:22:20+00:00 https://ncoda.org/pes/decitabine/ 2025-09-26T00:24:44+00:00 https://ncoda.org/pes/decitabine-and-cedazuridine/ 2025-09-26T00:27:18+00:00 https://ncoda.org/pes/duvelisib/ 2025-09-26T13:18:40+00:00 https://ncoda.org/pes/eltrombopag/ 2025-09-26T13:34:32+00:00 https://ncoda.org/pes/enasidenib/ 2025-09-26T13:37:13+00:00 https://ncoda.org/pes/encorafenib/ 2025-09-26T13:39:10+00:00 https://ncoda.org/pes/enfortumab-vedotin/ 2025-09-26T13:41:07+00:00 https://ncoda.org/pes/entrectinib/ 2025-09-26T13:43:03+00:00 https://ncoda.org/pes/erdafitinib/ 2025-09-26T13:51:59+00:00 https://ncoda.org/pes/eribulin/ 2025-09-26T13:54:58+00:00 https://ncoda.org/pes/eribulin-and-margetuximab/ 2025-09-26T13:56:58+00:00 https://ncoda.org/pes/erlotinib/ 2025-09-26T13:58:47+00:00 https://ncoda.org/pes/etoposide-vepesid-oral/ 2025-09-26T15:14:40+00:00 https://ncoda.org/pes/everolimus/ 2025-09-26T15:18:17+00:00 https://ncoda.org/pes/exemestane/ 2025-09-26T15:58:19+00:00 https://ncoda.org/pes/fedratinib/ 2025-09-26T15:59:47+00:00 https://ncoda.org/pes/fostamatinib/ 2025-09-26T16:13:31+00:00 https://ncoda.org/pes/fruquintinib/ 2025-09-26T16:15:42+00:00 https://ncoda.org/pes/futibatinib/ 2025-09-26T16:16:40+00:00 https://ncoda.org/pes/gefitinib/ 2025-09-26T16:18:02+00:00 https://ncoda.org/pes/gemcitabine/ 2025-09-26T16:19:33+00:00 https://ncoda.org/pes/gemcitabine-and-albumin-bound-paclitaxel/ 2025-09-26T16:22:04+00:00 https://ncoda.org/pes/gemox/ 2025-09-26T16:23:55+00:00 https://ncoda.org/pes/gilteritinib/ 2025-09-26T16:26:27+00:00 https://ncoda.org/pes/glasdegib/ 2025-09-26T16:27:35+00:00 https://ncoda.org/pes/ibrutinib/ 2025-09-26T16:42:57+00:00 https://ncoda.org/pes/idelalisib/ 2025-09-26T16:44:09+00:00 https://ncoda.org/pes/ivosidenib/ 2025-09-26T16:49:44+00:00 https://ncoda.org/pes/ixazomib/ 2025-09-26T16:51:13+00:00 https://ncoda.org/pes/lapatinib/ 2025-09-26T16:52:38+00:00 https://ncoda.org/pes/letrozole/ 2025-09-26T16:59:32+00:00 https://ncoda.org/pes/folfiri/ 2025-09-26T17:17:23+00:00 https://ncoda.org/pes/liposomal-doxorubicin/ 2025-09-26T17:22:20+00:00 https://ncoda.org/pes/lomustine/ 2025-09-26T17:23:50+00:00 https://ncoda.org/pes/lorlatinib/ 2025-09-26T17:25:27+00:00 https://ncoda.org/pes/lurbinectedin/ 2025-09-26T17:26:48+00:00 https://ncoda.org/pes/melphalan/ 2025-09-26T17:30:23+00:00 https://ncoda.org/pes/mercaptopurine-6-mp/ 2025-09-26T17:38:34+00:00 https://ncoda.org/pes/methotrexate/ 2025-09-26T17:41:44+00:00 https://ncoda.org/pes/mitotane/ 2025-09-26T17:45:44+00:00 https://ncoda.org/pes/mogamulizumab/ 2025-09-26T17:48:56+00:00 https://ncoda.org/pes/momelotinib/ 2025-09-26T17:52:12+00:00 https://ncoda.org/pes/nilutamide/ 2025-09-26T17:56:25+00:00 https://ncoda.org/resource/pqi-sodium-thiosulfate-injection-pedmark-to-prevent-platinum-induced-ototoxicity-in-pediatric-and-adolescent-or-young-adult-aya-patients/ 2025-09-26T18:02:08+00:00 https://ncoda.org/pes/olaparib/ 2025-09-26T22:40:41+00:00 https://ncoda.org/pes/paclitaxel-and-ramucirumab/ 2025-09-26T22:51:07+00:00 https://ncoda.org/pes/palbociclib/ 2025-09-26T22:58:13+00:00 https://ncoda.org/pes/folfiri-and-panitumumab/ 2025-09-26T23:07:18+00:00 https://ncoda.org/pes/pemigatinib/ 2025-09-26T23:29:53+00:00 https://ncoda.org/pes/pertuzumab-and-trastuzumab/ 2025-09-26T23:34:40+00:00 https://ncoda.org/pes/pexidartinib/ 2025-09-26T23:37:55+00:00 https://ncoda.org/pes/pirtobrutinib/ 2025-09-26T23:39:29+00:00 https://ncoda.org/pes/polatuzumab-vedotin-and-rituximab/ 2025-09-26T23:48:34+00:00 https://ncoda.org/pes/pomalidomide/ 2025-09-26T23:50:26+00:00 https://ncoda.org/pes/pralsetinib/ 2025-09-26T23:53:44+00:00 https://ncoda.org/pes/procarbazine/ 2025-09-26T23:55:33+00:00 https://ncoda.org/pes/quizartinib/ 2025-09-26T23:59:38+00:00 https://ncoda.org/pes/ramucirumab/ 2025-09-27T00:01:08+00:00 https://ncoda.org/pes/relugolix/ 2025-09-27T00:03:40+00:00 https://ncoda.org/pes/repotrectinib/ 2025-09-27T00:06:07+00:00 https://ncoda.org/pes/ribociclib/ 2025-09-27T00:07:44+00:00 https://ncoda.org/pes/rituximab-and-gemox/ 2025-09-27T00:13:51+00:00 https://ncoda.org/pes/lenalidomide-dexamethasone/ 2025-09-27T00:22:27+00:00 https://ncoda.org/pes/r-eshap/ 2025-09-27T00:33:35+00:00 https://ncoda.org/pes/r-epoch/ 2025-09-27T00:37:46+00:00 https://ncoda.org/pes/r-gdp/ 2025-09-27T00:40:44+00:00 https://ncoda.org/pes/ruxolitinib/ 2025-09-27T00:43:39+00:00 https://ncoda.org/pes/sacituzumab-govitecan/ 2025-09-27T00:44:57+00:00 https://ncoda.org/pes/sonidegib/ 2025-09-27T00:51:09+00:00 https://ncoda.org/pes/sotorasib/ 2025-09-27T00:53:26+00:00 https://ncoda.org/pes/talazoparib/ 2025-09-27T00:57:43+00:00 https://ncoda.org/pes/tamoxifen/ 2025-09-27T00:59:15+00:00 https://ncoda.org/pes/thioguanine/ 2025-09-27T01:04:23+00:00 https://ncoda.org/pes/tivozanib/ 2025-09-27T01:07:26+00:00 https://ncoda.org/pes/topotecan-oral/ 2025-09-27T01:09:08+00:00 https://ncoda.org/pes/trastuzumab/ 2025-09-27T01:13:25+00:00 https://ncoda.org/pes/carfilzomib-rituximab-and-dexamethasone/ 2025-09-27T02:11:20+00:00 https://ncoda.org/pes/folfiri-and-cetuximab/ 2025-09-27T02:22:38+00:00 https://ncoda.org/pes/pembrolizumab-and-ipilimumab/ 2025-09-27T02:42:05+00:00 https://ncoda.org/pes/bevacizumab-trifluridine-and-tipiracil/ 2025-09-28T21:38:23+00:00 https://ncoda.org/pes/pomalidomide-bortezomib-and-dexamethasone/ 2025-09-28T21:39:42+00:00 https://ncoda.org/pes/cyclophosphamide-doxorubicin-vincristine-and-prednisone/ 2025-09-28T22:12:07+00:00 https://ncoda.org/pes/da-epoch-r/ 2025-09-28T22:23:32+00:00 https://ncoda.org/pes/dd-mvac/ 2025-09-28T22:26:34+00:00 https://ncoda.org/pes/doxorubicin-ifosfamide-and-mesna/ 2025-09-28T22:39:01+00:00 https://ncoda.org/pes/nivolumab-and-folfox/ 2025-09-28T23:28:42+00:00 https://ncoda.org/resource/global-health-cancer-survivorship-and-advancing-equality/ 2025-10-02T14:24:30+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/09/Podcast-Episode-Feature-Image-48.jpg https://ncoda.org/resource/advancing-pharmacogenomics-in-oncology/ 2025-10-02T14:24:49+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/09/Podcast-Episode-Feature-Image-47.png https://ncoda.org/pes/mirdametinib/ 2025-10-02T22:42:53+00:00 https://ncoda.org/pes/nivolumab-and-hyaluronidase/ 2025-10-02T22:43:09+00:00 https://ncoda.org/pes/leucovorin-fluorouracil-and-oxaliplatin/ 2025-10-02T22:43:38+00:00 https://ncoda.org/pes/glofitamab/ 2025-10-02T22:43:55+00:00 https://ncoda.org/pes/vandetanib/ 2025-10-02T22:44:51+00:00 https://ncoda.org/pes/isatuximab-carfilzomib-and-dexamethasone/ 2025-10-02T22:45:08+00:00 https://ncoda.org/pes/epcoritamab/ 2025-10-02T22:45:26+00:00 https://ncoda.org/pes/trastuzumab-and-folfox/ 2025-10-02T22:46:55+00:00 https://ncoda.org/pes/tislelizumab-and-capox/ 2025-10-02T22:50:50+00:00 https://ncoda.org/pes/tislelizumab-capecitabine-and-cisplatin/ 2025-10-02T22:51:57+00:00 https://ncoda.org/pes/r-dhax/ 2025-10-02T22:52:08+00:00 https://ncoda.org/pes/penpulimab-carboplatin-and-gemcitabine/ 2025-10-02T22:52:38+00:00 https://ncoda.org/pes/pembrolizumab-gemcitabine-cisplatin/ 2025-10-02T22:52:45+00:00 https://ncoda.org/pes/pembrolizumab-capecitabine-and-cisplatin/ 2025-10-02T22:52:56+00:00 https://ncoda.org/pes/nivolumab-and-capox/ 2025-10-02T22:53:04+00:00 https://ncoda.org/pes/gemtuzumab-ozogamicin-73/ 2025-10-02T22:53:14+00:00 https://ncoda.org/pes/eshap/ 2025-10-02T22:54:29+00:00 https://ncoda.org/pes/durvalumab-and-tremelimumab/ 2025-10-02T22:54:37+00:00 https://ncoda.org/pes/bortezomib-lenalidomide-dexamethasone/ 2025-10-02T22:55:09+00:00 https://ncoda.org/pes/retifanlimab/ 2025-10-02T22:55:29+00:00 https://ncoda.org/pes/bevacizumab-and-folfox/ 2025-10-02T22:55:37+00:00 https://ncoda.org/pes/cabozantinib/ 2025-10-02T22:56:21+00:00 https://ncoda.org/pes/penpulimab-cisplatin-and-gemcitabine/ 2025-10-02T22:56:33+00:00 https://ncoda.org/pes/leucovorin-fluorouracil-and-cisplatin/ 2025-10-02T22:56:42+00:00 https://ncoda.org/pes/hyper-cvad-cycle-a/ 2025-10-02T22:56:51+00:00 https://ncoda.org/pes/gdp/ 2025-10-02T22:57:10+00:00 https://ncoda.org/pes/venetoclax/ 2025-10-02T22:57:40+00:00 https://ncoda.org/pes/tucatinib/ 2025-10-02T22:57:57+00:00 https://ncoda.org/pes/trifluridine-and-tipiracil/ 2025-10-02T23:05:38+00:00 https://ncoda.org/pes/rice/ 2025-10-02T23:06:01+00:00 https://ncoda.org/pes/ripretinib/ 2025-10-02T23:06:12+00:00 https://ncoda.org/pes/ponatinib/ 2025-10-02T23:06:22+00:00 https://ncoda.org/pes/osimertinib/ 2025-10-02T23:06:38+00:00 https://ncoda.org/pes/obinutuzumab/ 2025-10-02T23:06:46+00:00 https://ncoda.org/pes/nilotinib/ 2025-10-02T23:07:01+00:00 https://ncoda.org/pes/midostaurin/ 2025-10-02T23:08:19+00:00 https://ncoda.org/pes/ice/ 2025-10-02T23:08:45+00:00 https://ncoda.org/pes/hydroxyurea/ 2025-10-02T23:08:53+00:00 https://ncoda.org/pes/flutamide/ 2025-10-02T23:09:05+00:00 https://ncoda.org/pes/estramustine/ 2025-10-02T23:09:14+00:00 https://ncoda.org/pes/elacestrant/ 2025-10-02T23:10:43+00:00 https://ncoda.org/pes/brigatinib/ 2025-10-02T23:11:20+00:00 https://ncoda.org/pes/adagrasib/ 2025-10-02T23:11:33+00:00 https://ncoda.org/pes/tremelimumab/ 2025-10-02T23:11:50+00:00 https://ncoda.org/pes/toripalimab/ 2025-10-02T23:11:58+00:00 https://ncoda.org/pes/ipilimumab/ 2025-10-02T23:12:18+00:00 https://ncoda.org/pes/penpulimab/ 2025-10-02T23:12:27+00:00 https://ncoda.org/pes/ipilimumab-and-nivolumab/ 2025-10-02T23:12:35+00:00 https://ncoda.org/pes/nivolumab-cisplatin-fluorouracil/ 2025-10-02T23:13:18+00:00 https://ncoda.org/pes/hyper-cvad-cycle-b/ 2025-10-02T23:13:28+00:00 https://ncoda.org/pes/folfirinox/ 2025-10-02T23:13:36+00:00 https://ncoda.org/pes/pembrolizumab-cisplatin-fluorouracil/ 2025-10-02T23:13:54+00:00 https://ncoda.org/pes/doxorubicin-and-dacarbazine/ 2025-10-02T23:14:13+00:00 https://ncoda.org/pes/dose-dense-doxorubicin-and-cyclophosphamide/ 2025-10-02T23:14:21+00:00 https://ncoda.org/pes/cyclophosphamide-methotrexate-and-fluorouracil/ 2025-10-02T23:14:30+00:00 https://ncoda.org/pes/nivolumab-and-avd-doxorubicin-vinblastine-dacarbazine/ 2025-10-02T23:14:55+00:00 https://ncoda.org/pes/cytarabine-and-idarubicin-73/ 2025-10-02T23:15:04+00:00 https://ncoda.org/pes/cyclophosphamide-epirubicin-and-pembrolizumab/ 2025-10-02T23:15:14+00:00 https://ncoda.org/pes/atezolizumab/ 2025-10-02T23:16:08+00:00 https://ncoda.org/pes/vismodegib/ 2025-10-02T23:16:27+00:00 https://ncoda.org/pes/vemurafenib/ 2025-10-02T23:16:35+00:00 https://ncoda.org/pes/tretinoin/ 2025-10-02T23:16:44+00:00 https://ncoda.org/pes/thalidomide/ 2025-10-02T23:17:04+00:00 https://ncoda.org/pes/tepotinib/ 2025-10-02T23:17:12+00:00 https://ncoda.org/pes/sunitinib/ 2025-10-02T23:17:20+00:00 https://ncoda.org/pes/sorafenib/ 2025-10-02T23:17:28+00:00 https://ncoda.org/pes/selpercatinib/ 2025-10-02T23:17:35+00:00 https://ncoda.org/pes/selinexor/ 2025-10-02T23:17:42+00:00 https://ncoda.org/pes/rucaparib/ 2025-10-02T23:17:51+00:00 https://ncoda.org/pes/nivolumab-capecitabine-and-cisplatin/ 2025-10-03T00:16:07+00:00 https://ncoda.org/pes/zolbetuximab/ 2025-10-06T20:49:41+00:00 https://ncoda.org/pes/polatuzumab-vedotin/ 2025-10-06T20:58:55+00:00 https://ncoda.org/resource/pqi-initiating-mosunetuzumab-axgb-lunsumio-in-relapsed-refractory-follicular-lymphoma/ 2025-10-06T23:01:50+00:00 https://ncoda.org/resource/pqi-pegcetacoplan-empaveli-use-in-paroxysmal-nocturnal-hemoglobinuria/ 2025-10-06T23:04:38+00:00 https://ncoda.org/resource/pqi-enfortumab-vedotin-ejfv-padcev-management-for-advanced-or-metastatic-urothelial-carcinoma/ 2025-10-06T23:21:47+00:00 https://ncoda.org/resource/pqi-enfortumab-vedotin-ejfv-padcev-and-pembrolizumab-keytruda-management-for-advanced-or-metastatic-urothelial-carcinoma/ 2025-10-06T23:22:49+00:00 https://ncoda.org/resource/pqi-optimizing-venetoclax-treatment-of-acute-myeloid-leukemia/ 2025-10-06T23:26:59+00:00 https://ncoda.org/resource/pqi-oral-anticancer-medication-patient-management-workflow-evaluation-and-process-mapping/ 2025-10-07T17:27:47+00:00 https://ncoda.org/pes/how-to-categorize-cancer-drug-therapy/ 2025-10-07T19:27:11+00:00 https://ncoda.org/pes/flag-ida/ 2025-10-07T19:27:41+00:00 https://ncoda.org/pes/flag/ 2025-10-07T19:28:07+00:00 https://ncoda.org/pes/safe-handling-of-chemotherapy-taken-by-mouth/ 2025-10-07T19:31:44+00:00 https://ncoda.org/pes/vorinostat/ 2025-10-07T22:36:22+00:00 https://ncoda.org/pes/trabectedin/ 2025-10-07T22:40:31+00:00 https://ncoda.org/pes/tazemetostat/ 2025-10-07T22:41:43+00:00 https://ncoda.org/pes/cosibelimab/ 2025-10-07T22:42:47+00:00 https://ncoda.org/pes/tchp/ 2025-10-07T22:43:49+00:00 https://ncoda.org/pes/tch/ 2025-10-07T22:44:30+00:00 https://ncoda.org/pes/avelumab/ 2025-10-07T22:56:50+00:00 https://ncoda.org/pes/cemiplimab/ 2025-10-07T22:57:29+00:00 https://ncoda.org/pes/dostarlimab/ 2025-10-07T22:58:01+00:00 https://ncoda.org/pes/durvalumab/ 2025-10-07T22:58:38+00:00 https://ncoda.org/pes/carboplatin-pemetrexed-and-pembrolizumab/ 2025-10-07T23:02:49+00:00 https://ncoda.org/pes/pembrolizumab-and-albumin-bound-paclitaxel/ 2025-10-07T23:06:28+00:00 https://ncoda.org/pes/pembrolizumab-trastuzumab-and-folfox/ 2025-10-07T23:06:57+00:00 https://ncoda.org/pes/carboplatin-albumin-bound-paclitaxel-durvalumab-and-tremelimumab/ 2025-10-07T23:07:46+00:00 https://ncoda.org/pes/carboplatin-gemcitabine-durvalumab-and-tremelimumab/ 2025-10-07T23:08:28+00:00 https://ncoda.org/pes/carboplatin-pemetrexed-durvalumab-and-tremelimumab/ 2025-10-07T23:08:53+00:00 https://ncoda.org/pes/cisplatin-gemcitabine-durvalumab-and-tremelimumab/ 2025-10-07T23:09:57+00:00 https://ncoda.org/pes/cisplatin-pemetrexed-durvalumab-and-tremelimumab/ 2025-10-07T23:10:37+00:00 https://ncoda.org/pes/atezolizumab-and-bevacizumab/ 2025-10-07T23:11:09+00:00 https://ncoda.org/pes/atezolizumab-and-hyaluronidase/ 2025-10-07T23:11:38+00:00 https://ncoda.org/pes/elranatamab/ 2025-10-07T23:12:17+00:00 https://ncoda.org/pes/cisplatin-pemetrexed-and-nivolumab/ 2025-10-07T23:13:10+00:00 https://ncoda.org/pes/linvoseltamab/ 2025-10-07T23:18:09+00:00 https://ncoda.org/resource/advanced-breast-cancer-appropriate-patient-identification-with-abemaciclib-verzenio/ 2025-10-08T14:13:55+00:00 https://ncoda.org/resource/pqi-fruquintinib-fruzaqla/ 2025-10-08T14:15:01+00:00 https://ncoda.org/resource/pqi-elranatamab-elrexfio-for-the-treatment-of-relapsed-refractory-multiple-myeloma/ 2025-10-08T14:16:06+00:00 https://ncoda.org/resource/pqi-venetoclax-venclexta-for-the-treatment-of-acute-myeloid-leukemia/ 2025-10-08T14:16:35+00:00 https://ncoda.org/pes/trastuzumab-emtansine/ 2025-10-08T14:54:49+00:00 https://ncoda.org/pes/brentuximab-vedotin-doxorubicin-vinblastine-and-dacarbazine/ 2025-10-08T14:56:39+00:00 https://ncoda.org/pes/polatuzumab-vedotin-bendamustine-and-rituximab/ 2025-10-08T14:57:23+00:00 https://ncoda.org/pes/carboplatin-paclitaxel-and-pembrolizumab/ 2025-10-08T16:47:12+00:00 https://ncoda.org/pes/etoposide/ 2025-10-08T20:09:46+00:00 https://ncoda.org/pes/encorafenib-and-binimetinib/ 2025-10-08T22:28:14+00:00 https://ncoda.org/pes/vorasidenib/ 2025-10-08T22:33:59+00:00 https://ncoda.org/resource/zanubrutinib-brukinsa-treatment-discussion-guide/ 2025-10-09T13:27:22+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/06/Treatment-Discussion-Guide.jpg https://ncoda.org/resource/nirogacestat-ogsiveo-treatment-discussion-guide/ 2025-10-09T13:30:11+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/MIP-team.png https://ncoda.org/resource/pqi-darolutamide-nubeqa-in-the-treatment-of-non-metastatic-castration-resistant-prostate-cancer/ 2025-10-13T20:45:57+00:00 https://ncoda.org/resource/capivasertib-truqap-patient-management/ 2025-10-13T21:08:46+00:00 https://ncoda.org/pes/cyclophosphamide-doxorubicin-and-pembrolizumab/ 2025-10-13T22:31:15+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-fatigue/ 2025-10-13T22:41:22+00:00 https://ncoda.org/pes/telisotuzumab-vedotin/ 2025-10-20T22:48:45+00:00 https://ncoda.org/pes/carfilzomib-pomalidomide-and-dexamethasone/ 2025-10-20T22:59:45+00:00 https://ncoda.org/pes/carfilzomib-lenalidomide-and-dexamethasone/ 2025-10-20T23:06:39+00:00 https://ncoda.org/pes/carfilzomib-cyclophosphamide-and-dexamethasone/ 2025-10-20T23:17:32+00:00 https://ncoda.org/pes/bortezomib-and-dexamethasone/ 2025-10-20T23:24:10+00:00 https://ncoda.org/pes/capecitabine-and-mitomycin-with-radiation/ 2025-10-20T23:40:30+00:00 https://ncoda.org/pes/bortezomib/ 2025-10-20T23:50:03+00:00 https://ncoda.org/pes/atezolizumab-carboplatin-and-etoposide/ 2025-10-23T19:24:06+00:00 https://ncoda.org/pes/capecitabine-and-cisplatin/ 2025-10-23T21:29:46+00:00 https://ncoda.org/pes/cisplatin-fluorouracil-pembrolizumab-and-trastuzumab/ 2025-10-23T21:48:28+00:00 https://ncoda.org/pes/cisplatin-gemcitabine-and-durvalumab/ 2025-10-23T21:50:56+00:00 https://ncoda.org/pes/cisplatin/ 2025-10-23T22:01:40+00:00 https://ncoda.org/pes/datopotamab-deruxtecan/ 2025-10-23T23:40:16+00:00 https://ncoda.org/pes/dhax/ 2025-10-23T23:50:29+00:00 https://ncoda.org/pes/dhap/ 2025-10-23T23:52:42+00:00 https://ncoda.org/pes/docetaxel-and-cyclophosphamide/ 2025-10-23T23:54:22+00:00 https://ncoda.org/pes/thp/ 2025-10-25T01:49:24+00:00 https://ncoda.org/pes/doxorubicin-and-cyclophosphamide/ 2025-10-25T02:27:30+00:00 https://ncoda.org/pes/durvalumab-carboplatin-and-etoposide/ 2025-10-25T02:54:06+00:00 https://ncoda.org/pes/eflornithine/ 2025-10-25T03:00:10+00:00 https://ncoda.org/pes/concerns-regarding-the-use-of-dietary-supplements-during-cancer-treatment/ 2025-10-25T21:30:59+00:00 https://ncoda.org/pes/fluorouracil-and-cisplatin/ 2025-10-25T22:26:42+00:00 https://ncoda.org/pes/important-terms-for-cancer-medicines-you-take-by-mouth/ 2025-10-25T23:43:20+00:00 https://ncoda.org/pes/inotuzumab-ozogamicin/ 2025-10-25T23:47:47+00:00 https://ncoda.org/pes/specialty-pharmacy-insurance-terms/ 2025-10-25T23:52:33+00:00 https://ncoda.org/pes/larotrectinib/ 2025-10-26T00:12:58+00:00 https://ncoda.org/pes/lazertinib/ 2025-10-26T00:20:18+00:00 https://ncoda.org/pes/nivolumab-and-relatlimab/ 2025-10-26T22:46:07+00:00 https://ncoda.org/pes/pazopanib/ 2025-10-27T14:49:03+00:00 https://ncoda.org/pes/carboplatin-and-etoposide/ 2025-10-27T22:08:14+00:00 https://ncoda.org/pes/avutometinib-and-defactinib/ 2025-10-27T22:11:34+00:00 https://ncoda.org/pes/cisplatin-and-etoposide/ 2025-10-27T22:18:03+00:00 https://ncoda.org/pes/rituximab-and-hyaluronidase/ 2025-10-27T23:20:46+00:00 https://ncoda.org/pes/rituximab-cyclophosphamide-doxorubicin-vincristine-and-prednisone/ 2025-10-28T12:29:08+00:00 https://ncoda.org/pes/tislelizumab-and-folfox/ 2025-10-28T14:43:42+00:00 https://ncoda.org/pes/tislelizumab-fluorouracil-and-cisplatin/ 2025-10-28T21:59:28+00:00 https://ncoda.org/pes/cabozantinib-and-nivolumab/ 2025-10-28T22:07:42+00:00 https://ncoda.org/pes/durvalumab-and-flot/ 2025-10-28T22:28:07+00:00 https://ncoda.org/pes/lenalidomide/ 2025-10-28T22:36:35+00:00 https://ncoda.org/pes/sunvozertinib/ 2025-10-28T22:43:10+00:00 https://ncoda.org/pes/temozolomide/ 2025-10-28T22:47:14+00:00 https://ncoda.org/pes/tisotumab-vedotin/ 2025-10-28T22:52:53+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-acneiform-rash/ 2025-10-28T23:19:43+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-constipation/ 2025-10-28T23:24:53+00:00 https://ncoda.org/pes/understanding-and-managing-cytokine-release-syndrome/ 2025-10-28T23:30:38+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-diarrhea/ 2025-10-28T23:37:37+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-hair-loss/ 2025-10-28T23:45:29+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-hand-foot-syndrome-hand-foot-skin-reaction/ 2025-10-28T23:50:05+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-heartburn/ 2025-10-28T23:56:26+00:00 https://ncoda.org/pes/capivasertib/ 2025-10-29T00:01:40+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-hormonal-side-effects/ 2025-10-29T00:08:59+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-nausea-and-vomiting/ 2025-10-29T13:05:59+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-mouth-sores/ 2025-10-29T13:14:26+00:00 https://ncoda.org/pes/understanding-and-managing-immune-effector-cell-associated-neurotoxicity-syndrome-icans/ 2025-10-29T13:19:28+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-edema/ 2025-10-29T13:24:12+00:00 https://ncoda.org/pes/understanding-and-managing-treatment-related-taste-changes/ 2025-10-29T13:29:03+00:00 https://ncoda.org/pes/crizotinib/ 2025-10-29T16:09:29+00:00 https://ncoda.org/pes/fluorouracil-leucovorin-oxaliplatin-and-docetaxel/ 2025-10-30T12:16:16+00:00 https://ncoda.org/pes/daratumumab-and-vrd/ 2025-10-30T12:26:15+00:00 https://ncoda.org/pes/taletrectinib/ 2025-10-30T13:32:07+00:00 https://ncoda.org/pes/mirvetuximab-soravtansine/ 2025-10-30T17:08:28+00:00 https://ncoda.org/resource/abiraterone-acetate-patient-selection-and-management/ 2025-10-30T19:04:12+00:00 https://ncoda.org/resource/pqi-in-action-acalabrutinib-calquence-in-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma/ 2025-10-30T19:16:14+00:00 https://ncoda.org/resource/pqi-in-action-adagrasib-krazati/ 2025-10-30T19:25:09+00:00 https://ncoda.org/resource/androgen-deprivation-therapy-with-relugolix-orgovyx-2/ 2025-10-30T19:30:32+00:00 https://ncoda.org/resource/pqi-in-action-avapritinib-ayvakit-management-for-advanced-systemic-mastocytosis/ 2025-10-30T19:36:45+00:00 https://ncoda.org/resource/pqi-in-action-cabazitaxel-jevtana-for-patients-with-metastatic-castration-resistant-prostate-cancer/ 2025-10-30T21:11:32+00:00 https://ncoda.org/resource/pqi-in-action-cabazitaxel-jevtana-for-patients-with-metastatic-castration-resistant-prostate-cancer-2/ 2025-10-30T21:16:48+00:00 https://ncoda.org/resource/pqi-in-action-cemiplimab-rwlc-libtayo-patient-management/ 2025-10-30T21:26:54+00:00 https://ncoda.org/resource/pqi-in-action-clonoseq-next-generation-sequencing-for-minimal-residual-disease-testing-in-multiple-myeloma/ 2025-10-30T21:32:36+00:00 https://ncoda.org/resource/pqi-in-action-darolutamide-nubeqa-in-combination-with-docetaxel-taxotere-for-metastatic-hormone-sensitive-prostate-cancer/ 2025-10-30T21:40:44+00:00 https://ncoda.org/resource/pqi-in-action-enfortumab-vedotin-padcev-management-for-advanced-or-metastatic-urothelial-carcinoma/ 2025-10-30T22:05:22+00:00 https://ncoda.org/resource/pqi-in-action-enfortumab-vedotin-padcev-management-for-advanced-or-metastatic-urothelial-carcinoma-2/ 2025-10-30T22:09:47+00:00 https://ncoda.org/resource/pqi-in-action-enzalutamide-xtandi-in-castration-resistant-prostate-cancer-or-metastatic-castration-sensitive-prostate-cancer/ 2025-10-30T22:16:44+00:00 https://ncoda.org/resource/pqi-in-action-epcoritamab-epkinly-for-relapsed-refractory-diffuse-large-b-cell-lymphoma-and-follicular-lymphoma/ 2025-10-30T22:21:21+00:00 https://ncoda.org/resource/pqi-in-action-isatuximab-irfc-sarclisa-in-1q21-gain-oramplifications-in-relapsed-refractory-multiple-myeloma/ 2025-10-30T22:39:01+00:00 https://ncoda.org/resource/pqi-in-action-isatuximab-irfc-sarclisa-in-patients-with-relapsed-refractory-multiple-myeloma/ 2025-10-30T22:46:10+00:00 https://ncoda.org/resource/pqi-in-action-larotrectinib-vitrakvi-overview/ 2025-10-30T22:51:55+00:00 https://ncoda.org/resource/pqi-in-action-lurbinectedin-zepzelca-for-small-cell-lung-cancer/ 2025-10-30T23:19:48+00:00 https://ncoda.org/resource/pqi-in-action-tucatinib-tukysa-and-trastuzumab-in-her2-positive-metastatic-colorectal-cancer-2/ 2025-10-30T23:28:45+00:00 https://ncoda.org/resource/pqi-in-action-medically-integrated-dispensing-of-ixazomib-in-the-treatment-of-multiple-myeloma/ 2025-10-30T23:32:32+00:00 https://ncoda.org/resource/pqi-in-action-neratinib-nerlynx-diarrhea-management/ 2025-10-30T23:51:51+00:00 https://ncoda.org/resource/pqi-in-action-nirogacestat-use-in-management-of-adults-with-progressing-desmoid-tumors/ 2025-10-30T23:55:24+00:00 https://ncoda.org/pes/cobimetinib/ 2025-10-31T21:21:15+00:00 https://ncoda.org/pes/bevacizumab/ 2025-11-04T22:47:47+00:00 https://ncoda.org/pes/anastrozole/ 2025-11-04T22:56:56+00:00 https://ncoda.org/pes/rituximab/ 2025-11-05T00:50:10+00:00 https://ncoda.org/pes/enfortumab-vedotin-and-pembrolizumab/ 2025-11-05T01:04:21+00:00 https://ncoda.org/pes/dostarlimab-carboplatin-and-paclitaxel/ 2025-11-05T01:12:26+00:00 https://ncoda.org/resource/toolkit-simplify-cll-tracking-in-oncology-practices/ 2025-11-05T16:29:35+00:00 https://ncoda.org/resource/readiness-tracker/ 2025-11-05T21:10:38+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/ReadinessTrackerMOCKUP.jpg https://ncoda.org/pes/lenvatinib-and-pembrolizumab/ 2025-11-05T22:40:28+00:00 https://ncoda.org/pes/axitinib-and-pembrolizumab/ 2025-11-05T22:41:39+00:00 https://ncoda.org/resource/the-realities-of-ethics-in-oncology/ 2025-11-06T15:03:24+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/10/Podcast-Episode-Feature-Image-52.jpg https://ncoda.org/resource/mental-strength-at-work/ 2025-11-06T15:03:52+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/10/Podcast-Episode-Feature-Image-51.png https://ncoda.org/resource/a-haven-of-healing/ 2025-11-06T15:04:21+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/10/Podcast-Episode-Feature-Image-50.png https://ncoda.org/resource/healing-through-sound-a-breast-cancer-journey/ 2025-11-06T15:04:48+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/10/Podcast-Episode-Feature-Image-49.png https://ncoda.org/resource/pqi-datopotamab-deruxtecan-datroway-prophylaxis-and-management-of-adverse-events/ 2025-11-07T18:03:31+00:00 https://ncoda.org/resource/advancing-clinical-research/ 2025-11-11T19:35:53+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Podcast-Episode-Feature-Image-53.jpg https://ncoda.org/pes/fluorouracil-and-mitomycin-with-radiation/ 2025-11-13T13:45:57+00:00 https://ncoda.org/pes/brentuximab-vedotin-lenalidomide-and-rituximab/ 2025-11-17T15:39:32+00:00 https://ncoda.org/pes/isatuximab-and-vrd/ 2025-11-17T16:56:35+00:00 https://ncoda.org/pes/olaparib-abiraterone-and-prednisone/ 2025-11-17T21:46:28+00:00 https://ncoda.org/pes/imetelstat/ 2025-11-17T22:37:57+00:00 https://ncoda.org/pes/revumenib/ 2025-11-17T22:53:25+00:00 https://ncoda.org/pes/vimseltinib/ 2025-11-17T22:58:29+00:00 https://ncoda.org/resource/brentuximab-vedotin-adcetris-neuropathy-and-neutropenia-management/ 2025-11-17T23:11:46+00:00 https://ncoda.org/resource/pqi-revumenib-revuforj-for-the-management-of-acute-leukemia/ 2025-11-17T23:16:21+00:00 https://ncoda.org/resource/honoring-veterans-through-early-cancer-detection/ 2025-11-19T20:41:11+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Podcast-Episode-Feature-Image-54.png https://ncoda.org/resource/pqi-gilteritinib-xospata-for-relapsed-refractory-acute-myeloid-leukemia/ 2025-11-20T19:03:34+00:00 https://ncoda.org/pes/capecitabine/ 2025-11-21T14:23:08+00:00 https://ncoda.org/pes/doxorubicin-bleomycin-vinblastine-and-dacarbazine/ 2025-11-24T23:21:52+00:00 https://ncoda.org/pes/elotuzumab-and-pd/ 2025-11-25T00:24:15+00:00 https://ncoda.org/pes/zongertinib/ 2025-11-25T01:34:43+00:00 https://ncoda.org/pes/enzalutamide/ 2025-11-25T19:22:12+00:00 https://ncoda.org/resource/pqi-in-action-oral-formulation-of-decitabine-and-cedazuridine-inqovi-for-hematological-malignancies-2/ 2025-11-29T14:41:26+00:00 https://ncoda.org/resource/pqi-in-action-selinexor-xpoviopatient-management/ 2025-11-30T14:44:00+00:00 https://ncoda.org/resource/pqi-in-action-selpercatinib-retevmo-genomic-testing-and-management/ 2025-11-30T14:50:54+00:00 https://ncoda.org/resource/pqi-in-action-tazemetostat-tazverikmanagement-in-relapsed-refractory-follicular-lymphoma/ 2025-11-30T14:59:05+00:00 https://ncoda.org/resource/pqi-in-action-tucatinib-tukysa-and-trastuzumab-in-her2-positive-metastatic-colorectal-cancer/ 2025-11-30T15:49:08+00:00 https://ncoda.org/resource/pqi-in-action-zanubrutinib-brukinsa-patient-selection-and-management-in-mantle-cell-lymphoma-2-2/ 2025-11-30T16:38:57+00:00 https://ncoda.org/resource/pqi-in-action-fruqintinib/ 2025-11-30T16:47:36+00:00 https://ncoda.org/resource/pqi-in-action-sonidegib/ 2025-11-30T16:49:49+00:00 https://ncoda.org/resource/putting-bispecific-t-cell-engagers-into-action/ 2025-11-30T18:37:47+00:00 https://ncoda.org/resource/engaging-with-bispecific-t-cell-engagers/ 2025-11-30T18:45:31+00:00 https://ncoda.org/resource/clearing-up-confusion-around-bispecific-antibodies/ 2025-11-30T18:47:11+00:00 https://ncoda.org/pes/daratumumab-and-krd/ 2025-12-05T00:20:02+00:00 https://ncoda.org/pes/selumetinib/ 2025-12-09T21:53:06+00:00 https://ncoda.org/resource/avapritinib-ayvakit-management-for-advanced-systemic-mastocytosis/ 2025-12-11T23:48:06+00:00 https://ncoda.org/resource/avapritinib-ayvakit-for-indolent-systemic-mastocytosis/ 2025-12-11T23:50:58+00:00 https://ncoda.org/resource/a-season-of-gratitude/ 2025-12-12T16:38:40+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Podcast-Episode-Feature-Image-56.png https://ncoda.org/resource/avapritinib-ayvakit-management-for-gastrointestinal-stromal-tumor/ 2025-12-14T23:03:16+00:00 https://ncoda.org/resource/pqi-ivosidenib-tibsovo-and-management-of-idh1-mutant-acute-myeloid-leukemia/ 2025-12-14T23:12:17+00:00 https://ncoda.org/pes/trastuzumab-fluorouracil-leucovorin-and-cisplatin/ 2025-12-14T23:25:06+00:00 https://ncoda.org/pes/retifanlimab-carboplatin-and-paclitaxel/ 2025-12-14T23:36:38+00:00 https://ncoda.org/pes/pembrolizumab-trastuzumab-and-capox/ 2025-12-14T23:45:45+00:00 https://ncoda.org/pes/capecitabine-and-oxaliplatin-with-radiation-therapy/ 2025-12-14T23:58:18+00:00 https://ncoda.org/pes/pembrolizumab-trastuzumab-capecitabine-and-cisplatin/ 2025-12-15T00:11:14+00:00 https://ncoda.org/pes/trastuzumab-capecitabine-and-cisplatin/ 2025-12-15T00:19:19+00:00 https://ncoda.org/pes/imlunestrant/ 2025-12-15T00:28:31+00:00 https://ncoda.org/resource/pqi-in-action-zolbetuximab-vyloy-for-gastroesophageal-cancers/ 2025-12-17T20:45:02+00:00 https://ncoda.org/resource/immunotherapy-and-the-mymelanoma-project/ 2025-12-18T14:13:44+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/12/Podcast-Episode-Feature-Image-57.jpg https://ncoda.org/resource/pqi-zanubrutinib-brukinsa-treatment-for-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma/ 2025-12-18T14:36:47+00:00 https://ncoda.org/resource/pqi-zanubrutinib-brukinsa-patient-selection-and-management/ 2025-12-18T14:37:01+00:00 https://ncoda.org/pes/bosutinib/ 2025-12-22T20:01:33+00:00 https://ncoda.org/pes/zoledronic-acid/ 2025-12-22T21:44:41+00:00 https://ncoda.org/pes/pamidronate/ 2025-12-22T21:47:07+00:00 https://ncoda.org/pes/denosumab/ 2025-12-22T22:06:23+00:00 https://ncoda.org/pes/leuprolide/ 2025-12-22T22:13:38+00:00 https://ncoda.org/pes/mosunetuzumab/ 2025-12-22T22:23:42+00:00 https://ncoda.org/pes/brentuximab-vedotin/ 2025-12-22T22:30:00+00:00 https://ncoda.org/pes/tovorafenib/ 2025-12-22T23:18:33+00:00 https://ncoda.org/pes/trastuzumab-fluorouracil-and-cisplatin/ 2025-12-23T00:55:30+00:00 https://ncoda.org/pes/zanubrutinib/ 2026-01-02T21:35:39+00:00 https://ncoda.org/pes/dabrafenib/ 2026-01-02T21:40:49+00:00 https://ncoda.org/pes/talazoparib-and-enzalutamide/ 2026-01-02T22:04:17+00:00 https://ncoda.org/resource/elranatamab-treatment-support-kits/ 2026-01-06T17:47:32+00:00 https://ncoda.org/pes/pacritinib/ 2026-01-11T23:46:10+00:00 https://ncoda.org/pes/trastuzumab-deruxtecan/ 2026-01-11T23:54:39+00:00 https://ncoda.org/resource/setting-the-stage-for-treatment-decisions-in-cll/ 2026-01-13T19:08:32+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/01/Treatment-Decisions.jpg https://ncoda.org/resource/empowering-patients-through-choice-and-communication-copy/ 2026-01-13T19:12:27+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/8.jpg https://ncoda.org/resource/empowering-patients-through-choice-and-communication/ 2026-01-13T19:16:13+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Patient-Considerations.jpg https://ncoda.org/resource/zanubrutinibs-cardiovascular-profile/ 2026-01-13T19:20:07+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Cardiovascular-Profile.jpg https://ncoda.org/resource/practical-aspects-of-prescribing-zanurbutinib-copy/ 2026-01-13T19:22:58+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Side-Effects.jpg https://ncoda.org/resource/practical-aspects-of-prescribing-zanurbutinib/ 2026-01-13T19:25:27+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Prescribing.jpg https://ncoda.org/resource/why-zanubrutinib-is-a-meaningful-option/ 2026-01-13T19:27:46+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/A-Meaningful-Option.jpg https://ncoda.org/resource/cll-microlearning-considerations-for-1st-line-therapy/ 2026-01-13T19:34:36+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/1st-Line-of-Therapy-1.jpg https://ncoda.org/resource/pqi-streamlining-enrollment-in-the-medicare-prescription-payment-plan-mppp/ 2026-01-14T23:38:20+00:00 https://ncoda.org/pes/niraparib/ 2026-01-15T00:23:41+00:00 https://ncoda.org/pes/asciminib/ 2026-01-15T00:27:19+00:00 https://ncoda.org/pes/pembrolizumab-and-berahyaluronidase-alfa/ 2026-01-15T13:30:21+00:00 https://ncoda.org/pes/lanreotide/ 2026-01-15T13:40:40+00:00 https://ncoda.org/pes/encorafenib-cetuximab-and-folfox/ 2026-01-15T13:52:31+00:00 https://ncoda.org/pes/goserelin/ 2026-01-15T14:02:17+00:00 https://ncoda.org/pes/ensartinib/ 2026-01-15T14:15:34+00:00 https://ncoda.org/pes/sirolimus-protein-bound-particles/ 2026-01-15T14:22:09+00:00 https://ncoda.org/pes/abiraterone-and-niraparib/ 2026-01-15T15:10:28+00:00 https://ncoda.org/resource/inavolisib-treatment-support-kits/ 2026-01-15T16:31:29+00:00 https://ncoda.org/resource/up-close-with-elranatamab/ 2026-01-20T17:59:20+00:00 https://ncoda.org/resource/up-close-with-epcoritamab/ 2026-01-21T00:12:11+00:00 https://ncoda.org/resource/up-close-with-glofitamab/ 2026-01-21T00:14:47+00:00 https://ncoda.org/resource/up-close-with-linvoseltamab/ 2026-01-21T00:15:51+00:00 https://ncoda.org/resource/up-close-with-mosunetuzumab/ 2026-01-21T00:18:53+00:00 https://ncoda.org/resource/up-close-with-talquetamab/ 2026-01-21T00:19:28+00:00 https://ncoda.org/resource/up-close-with-tarlatamab/ 2026-01-21T00:22:01+00:00 https://ncoda.org/resource/up-close-with-tebentafusp/ 2026-01-21T00:25:09+00:00 https://ncoda.org/pes/abemaciclib/ 2026-01-21T20:31:19+00:00 https://ncoda.org/pes/docetaxel/ 2026-01-23T00:36:32+00:00 https://ncoda.org/resource/pqi-epcoritamab-epkinly-for-relapsed-refractory-diffuse-large-b-cell-lymphoma-and-follicular-lymphoma/ 2026-01-23T15:46:58+00:00 https://ncoda.org/pes/blinatumomab/ 2026-01-23T19:36:51+00:00 https://ncoda.org/resource/we-won-the-battle-now-lets-paddle/ 2026-01-23T19:53:36+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Podcast-Episode-Feature-Image-55.jpg https://ncoda.org/pes/imatinib/ 2026-01-23T20:00:16+00:00 https://ncoda.org/pes/regorafenib/ 2026-01-23T20:54:24+00:00 https://ncoda.org/pes/avapritinib/ 2026-01-23T21:18:47+00:00 https://ncoda.org/pes/luspatercept/ 2026-01-23T21:55:09+00:00 https://ncoda.org/resource/pqi-in-action-darolutamide-nubeqa/ 2026-01-27T18:10:29+00:00 https://ncoda.org/pes/pegfilgrastim/ 2026-01-28T00:36:11+00:00 https://ncoda.org/pes/filgrastim/ 2026-01-28T00:43:08+00:00 https://ncoda.org/pes/sevabertinib/ 2026-01-28T00:51:41+00:00 https://ncoda.org/pes/fulvestrant/ 2026-01-28T00:56:48+00:00 https://ncoda.org/pes/ziftomenib/ 2026-01-28T01:05:43+00:00 https://ncoda.org/resource/toolkit-optimize-cll-care-in-epic/ 2026-02-02T22:20:13+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/11/Untitled-design-26.jpg https://ncoda.org/pes/axatilimab/ 2026-02-03T00:21:46+00:00 https://ncoda.org/pes/eculizumab/ 2026-02-03T00:41:24+00:00 https://ncoda.org/pes/atezolizumab-and-lurbinectedin/ 2026-02-03T00:49:21+00:00 https://ncoda.org/pes/trastuzumab-deruxtecan-and-pertuzumab/ 2026-02-03T01:07:43+00:00 https://ncoda.org/pes/darbepoetin-alfa/ 2026-02-03T01:16:19+00:00 https://ncoda.org/pes/amivantamab-and-hyaluronidase/ 2026-02-03T01:25:03+00:00 https://ncoda.org/pes/nivolumab/ 2026-02-03T15:09:59+00:00 https://ncoda.org/resource/pacritinib-treatment-support-kits/ 2026-02-03T20:36:41+00:00 https://ncoda.org/pes/irinotecan/ 2026-02-03T23:48:13+00:00 https://ncoda.org/pes/toremifene/ 2026-02-03T23:52:59+00:00 https://ncoda.org/pes/azacitidine-and-venetoclax/ 2026-02-03T23:59:24+00:00 https://ncoda.org/resource/theranostics-the-new-era-of-targeted-imaging-therapy/ 2026-02-04T18:56:48+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/12/Podcast-Episode-Feature-Image-58.jpg https://ncoda.org/resource/oncology-workforce-collaborative/ 2026-02-09T17:39:00+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast_FeatureImage_-3.png https://ncoda.org/pes/doxorubicin/ 2026-02-09T23:35:09+00:00 https://ncoda.org/pes/dabrafenib-and-trametinib/ 2026-02-09T23:40:32+00:00 https://ncoda.org/pes/trametinib/ 2026-02-09T23:43:20+00:00 https://ncoda.org/resource/pqi-her2-immunohistochemistry-testing-in-metastatic-breast-cancer-guiding-treatment-decisions-and-the-role-of-sacituzumab-govitecan/ 2026-02-12T21:21:18+00:00 https://ncoda.org/pes/inavolisib/ 2026-02-18T00:35:30+00:00 https://ncoda.org/pes/pembrolizumab-carboplatin-and-paclitaxel/ 2026-02-18T00:47:42+00:00 https://ncoda.org/pes/trilaciclib/ 2026-02-18T01:05:00+00:00 https://ncoda.org/pes/methotrexate-cytarabine-thiotepa-and-rituximab/ 2026-02-18T01:23:14+00:00 https://ncoda.org/pes/polatuzumab-vedotin-rituximab-cyclophosphamide-doxorubicin-and-prednisone/ 2026-02-18T23:10:31+00:00 https://ncoda.org/pes/epcoritamab-and-r2/ 2026-02-18T23:41:15+00:00 https://ncoda.org/pes/octreotide/ 2026-02-18T23:48:57+00:00 https://ncoda.org/pes/zanidatamab/ 2026-02-18T23:58:04+00:00 https://ncoda.org/pes/zenocutuzumab/ 2026-02-19T00:06:46+00:00 https://ncoda.org/pes/daratumumab-and-rd/ 2026-02-19T00:12:29+00:00 https://ncoda.org/pes/daratumumab-and-pd/ 2026-02-19T00:16:58+00:00 https://ncoda.org/pes/daratumumab-and-kd/ 2026-02-19T00:20:58+00:00 https://ncoda.org/resource/from-reporter-to-mip-advocate/ 2026-02-19T13:33:42+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/01/Podcast-Episode-Feature-Image-59.png https://ncoda.org/resource/bispecific-antibody-therapy-resource-guide/ 2026-02-19T18:06:09+00:00 https://ncoda.org/resource/up-close-with-blinatumomab/ 2026-02-25T21:09:22+00:00 https://ncoda.org/resource/up-close-with-teclistamab/ 2026-02-25T21:10:35+00:00 https://ncoda.org/resource/connecting-oncology-care-across-borders/ 2026-02-26T20:58:50+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/02/Podcast-Episode-Feature-Image-60.png https://ncoda.org/pes/nirogacestat/ 2026-03-04T23:58:47+00:00 https://ncoda.org/pes/eflapegrastim/ 2026-03-05T00:05:30+00:00 https://ncoda.org/pes/efbemalenograstim/ 2026-03-05T00:12:54+00:00 https://ncoda.org/pes/lutetium-lu-177-vipivotide-tetraxetan/ 2026-03-05T00:26:39+00:00 https://ncoda.org/pes/lutetium-lu-177-dotatate/ 2026-03-05T00:27:10+00:00 https://ncoda.org/resource/bispecific-treatment-support-kits/ 2026-03-05T00:36:00+00:00 https://ncoda.org/pes/lenvatinib/ 2026-03-08T21:07:32+00:00 https://ncoda.org/pes/olutasidenib/ 2026-03-08T21:13:48+00:00 https://ncoda.org/pes/cladribine/ 2026-03-08T21:24:25+00:00 https://ncoda.org/pes/high-dose-methotrexate/ 2026-03-08T21:36:41+00:00 https://ncoda.org/pes/decitabine-and-venetoclax/ 2026-03-08T21:43:09+00:00 https://ncoda.org/resource/pqi-daratumumab-darzalex-for-multiple-myeloma/ 2026-03-08T21:54:29+00:00 https://ncoda.org/pes/abiraterone-and-prednisone/ 2026-03-09T22:41:16+00:00 https://ncoda.org/pes/micronized-formulation-abiraterone-and-methylprednisolone/ 2026-03-09T22:46:19+00:00 https://ncoda.org/pes/cetuximab-plus-radiation/ 2026-03-09T23:08:57+00:00 https://ncoda.org/pes/cetuximab/ 2026-03-09T23:15:17+00:00 https://ncoda.org/pes/panitumumab/ 2026-03-10T13:22:01+00:00 https://ncoda.org/pes/neratinib/ 2026-03-11T22:50:17+00:00 https://ncoda.org/pes/amivantamab-and-lazertinib/ 2026-03-11T22:57:36+00:00 https://ncoda.org/pes/daratumumab-and-cybord/ 2026-03-11T23:05:37+00:00 https://ncoda.org/pes/deferasirox/ 2026-03-11T23:15:28+00:00 https://ncoda.org/pes/lenalidomide-and-rituximab/ 2026-03-11T23:20:50+00:00 https://ncoda.org/pes/acalabrutinib-and-br/ 2026-03-11T23:33:34+00:00 https://ncoda.org/resource/preventing-blood-clots-in-cancer-care/ 2026-03-19T14:15:54+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/03/Podcast-Episode-Feature-Image-63.jpg https://ncoda.org/resource/culturally-competency-care-in-oncology/ 2026-03-19T16:00:44+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2025/03/Podcast-Episode-Feature-Image-16.jpg https://ncoda.org/resource/bringing-care-closer-to-home-advancing-rural-oncology/ 2026-03-20T18:15:06+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/02/Podcast-Episode-Feature-Image-61.jpg https://ncoda.org/resource/no-room-for-shortages-protecting-patients-through-advocacy-and-action/ 2026-03-20T18:16:42+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/03/Podcast-Episode-Feature-Image-62.jpg https://ncoda.org/resource/modern-antibody-drug-conjugates-and-new-cinv-challenges/ 2026-03-26T00:00:00+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/03/Podcast-Episode-Feature-Image-66.jpg https://ncoda.org/resource/best-practices-for-subcutaneous-administration-of-anticancer-therapies/ 2026-03-26T13:02:32+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/03/Podcast-Episode-Feature-Image-65.jpg https://ncoda.org/pes/acalabrutinib/ 2026-04-01T23:43:52+00:00 https://ncoda.org/resource/s10-e7-scaling-hope-the-future-of-cell-therapy-access/ 2026-04-02T00:18:57+00:00 https://ncoda90f71ba7b4.blob.core.windows.net/blobncoda90f71ba7b4/wp-content/uploads/2026/04/Podcast-Episode-Feature-Image-67.jpg https://ncoda.org/pes/ibrutinib-and-rituximab/ 2026-04-03T04:27:50+00:00 https://ncoda.org/pes/pembrolizumab/ 2026-04-05T23:04:14+00:00 https://ncoda.org/pes/paclitaxel/ 2026-04-05T23:19:21+00:00 https://ncoda.org/pes/belantamab-mafodotin/ 2026-04-05T23:32:15+00:00 https://ncoda.org/pes/capecitabine-and-oxaliplatin/ 2026-04-05T23:43:00+00:00 https://ncoda.org/pes/pembrolizumab-and-gvd/ 2026-04-06T00:03:28+00:00 https://ncoda.org/resource/pqi-belantamab-mafodotin-blenrep-for-the-management-of-multiple-myeloma/ 2026-04-06T12:53:08+00:00 https://ncoda.org/pes/liposomal-irinotecan-fluorouracil-and-leucovorin/ 2026-04-06T20:15:53+00:00 https://ncoda.org/pes/liposomal-irinotecan-leucovorin-fluorouracil-and-oxaliplatin/ 2026-04-06T20:22:05+00:00 https://ncoda.org/pes/cladribine-and-rituximab/ 2026-04-06T23:17:17+00:00 https://ncoda.org/pes/teclistamab-and-talquetamab/ 2026-04-06T23:32:36+00:00 https://ncoda.org/pes/brentuximab-vedotin-etoposide-cyclophosphamide-doxorubicin-dacarbazine-and-dexamethasone/ 2026-04-06T23:46:46+00:00 https://ncoda.org/pes/doxorubicin-vinblastine-and-dacarbazine/ 2026-04-06T23:56:27+00:00 https://ncoda.org/pes/rituximab-cyclophosphamide-vincristine-and-prednisone/ 2026-04-07T00:05:32+00:00 https://ncoda.org/resource/pqi-sutimlimab-jome-enjaymo-for-the-management-of-hemolysis-in-cold-agglutinin-disease-cad/ 2026-04-07T00:22:25+00:00 https://ncoda.org/resource/pqi-in-action-sutimlimab-jome-enjaymo-for-the-management-of-hemolysis-in-cold-agglutinin-disease-cad/ 2026-04-08T05:56:16+00:00